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ABSTRACT 
Protein misfolding has a major implication in the development of neurodegenerative 
diseases like Alzheimer’s, Parkinson’s, Prions, Huntington’s and dementia. Elucidation of 
misfolded protein neurotoxicity for such chronic diseases has been challenging to model 
in the lab. Using cell cultures, the biology of misfolded proteins can be studied in short 
term, but the biologically integrated models remain to be established for long-term 
modeling. Therefore, in chapter I, we established an organotypic brain slice culture model 
that maintains the 3-dimensional environment and functionally relevance for chronic 
studies. Further, we have experimentally demonstrated the applications such as viability 
assessment, response to toxicants, cytokine release, modeling traumatic brain injury, 
targeted gene delivery. In chapter II, we report a novel organotypic slice culture assay 
coupled with seeding assays such as real-time quaking-induced conversion (OSCAR) 
assay. We hypothesized that the brain slice cultures coupled with sensitive readouts would 
provide fast and efficient alternative to modeling prions ex-vivo. OSCAR model was 
characterized for seeding activity at various time points and the titers are quantified. 
OSCAR supports investigating the biological mechanisms of prions and supports screening 
of anti-prion therapeutics. chronic wasting disease (CWD) is a prion disease of cervids that 
has been rapidly expanding in several states in USA including Iowa and Canada. Therefore, 
in chapter III, I developed a CWD brain slice culture model to characterize the CWD 
prions. Using traditional prion detection and ultra-sensitive detection such as Real-Time 
Quaking-Induced Conversion (RT-QuIC) and Protein Misfolding Cyclic Amplification 
(PMCA), we characterize the seeding ability of CWD prions. Further, we demonstrate 
infectious ability of the CWD prions from slices to infect the mice. We also demonstrate 
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the diagnostic ability of this model to detect CWD prions from a biological sample. 
Environmental factors such as Manganese can induce neuroimmune transformations that 
possibly alter the course of neurodegenerative processes. Therefore, in chapter IV, we 
systemically characterized the transcriptome of microglia in response to the neurotoxicant 
Manganese, misfolded α-syn, and the influence of their interaction. Our findings provide 
novel insights into global transcriptome of microglia. α-syn predominately activated innate 
immune genes particularly, cytokine and chemokines, TNF, NF-kB, and TLR signaling. In 
contrast, Mn caused distinct changes to pathways related to cellular senescence, NOD-like 
receptor signaling, HIF-1 signaling, and pyrimidine metabolism. Mn and α-syn co-
treatment caused major perturbations in Rho GTPase signaling and inflammasome 
activation. Co-treatment also caused profound changes in transcripts that triggered 
microglia to switch to their more cytotoxic, M1 phenotype. Collectively, we report the 
brain slice cultures to model the in-vivo like propagation of amyloids in environmentally 
linked neurodegenerative disorders. The reliability of this quantitative model for protein 
misfolding diseases could help us in understanding the mechanisms of diseases and to 
identify potential therapeutic targets. Additionally, we identified novel microglial genes 
and pathways that are perturbated in response to Mn and α-syn that allow us to discover 




CHAPTER I: GENERAL INTRODUCTION 
Thesis Layout and Organization 
The alternative format was chosen for this dissertation and consists of manuscripts that have 
either been published or are in preparation for submission. There is a general introduction 
containing merged literature review and research, three research chapters in the format of their 
corresponding journals, and a general conclusions/future directions section. Each research 
chapter contains references in the format of the journal it was published, or it will be submitted 
to.  
In chapter-I, we review the current state of organotypic slice cultures for modeling 
protein misfolding biology. We also develop this ex-vivo method of brain slice cultures from 
various brain regions and demonstrate this model as a faithful method to understand the disease 
process. Additionally, this model is also suitable to study the compounds of toxicological 
interest and environmental exposure such as Manganese, Lead, MPP+, 6-OHDA that are 
implicated in Parkinson’s disease models.  
Chapter-II is published in the journal Scientific Reports. In this manuscript, we report 
the integrated organotypic slice culture models coupled to RT-QuIC assay (OSCAR) to study 
the prion misfolding. The conclusion is that the OSCAR model can be a practical, sensitive, 
and fast approach to study slow progressive neurodegeneration in the lab setting. Another 
advantage of using this model is studying the misfolded proteins in the context of 3D 
environment and can support the studies in an intact brain-like environment for several weeks.  
In Chapter-III, the robustness of OSCAR model allowed me to characterize another 
strain of misfolded prion, that causes chronic wasting disease (CWD) in Cervids and have a 
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public health concern. CWD is a devastating disease that been rapidly expanding to several 
states in the USA and have a zoonotic concern. This manuscript will be submitted to the journal 
Scientific Reports. 
In chapter-IV, we provide a transcriptome analysis of misfolded α-Synuclein and 
Manganese (Mn) induced changes in the microglia. Using this study, we elucidate gene-
environment interactions and to identify several important genes and signaling pathways. This 
manuscript will be submitted to journal Glia. 
 In chapter V, I summarize general conclusions and pointing some important directions 
that have potential to become translational targets. 
This dissertation contains the experimental results obtained by the author during his 
Ph.D. study under the supervision of his major professor Dr. Anumantha G. Kanthasamy at 
Iowa State University, Department of Biomedical Sciences. 
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CHAPTER II: BRAIN SLICE CULTURES FOR EX-VIVO MODELING OF 
NEURODEGENERATIVE DISORDERS: CURRENT PROGRESS AND FUTURE 
PERSPECTIVES 
A manuscript to be submitted to Toxicological Sciences 
Naveen Kondru1, Sireesha Manne1, Adhithaya Charli1, Gary Zenitsky1, Carrie Berg1, Huajun 
Jin, Vellareddy Anantharam1, Arthi Kanthasamy1, and Anumantha Kanthasamy1* 
1. Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State 
University, Ames, IA 50011, USA. 
* Corresponding author:  akanthas@iastate.edu 
Abstract 
Modeling of protein misfolding ex-vivo in neurodegenerative disorders is crucial for the 
advancement of biologically relevant modeling. Brain slices support salient features of 
amyloid pathology and faithfully recapitulate the 3D environment and cellular diversity. 
Protein misfolding and aggregation has been increasingly important as a pathological event in 
neurodegenerative diseases and cancer, but biological modeling of this phenomena remains to 
be a challenge. The common hallmark manifestation in the degenerative process is the 
formation of abnormal aggregates of the proteins. While cellular models served to understand 
some of the mechanisms, organotypic slice cultures prove to be a realistic model for the 
advancement as the biologically relevant models. Here, we discuss the evolution of brain slice 
cultures for broad applications in diseases such as Alzheimer’s, Parkinson’s, Huntington, ALS 
and Prion diseases. We also provide experimental evidence to demonstrate the suitability of 
brain slices for long-term biological modeling of neurodegeneration and environment 
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connected neurotoxic mechanism. Further, we demonstrate targeted genetic manipulation 
using viral vectors that can be explored for ex-vivo disease modeling or therapeutic 
development. Finally, we describe a novel TBI slice culture model using a multi-electrode 
array to assess electrophysiological activity. In summary, we review the current state of brain 
slices to model chronic neurodegeneration, demonstrate assessment of flow cytometry-based 
cell viability, multiplex cytokine detection and established a novel TBI model. (NIH ES 19276 
and ES10586 and W. Eugene Linda Lloyd Endowed Chair)  
Introduction 
Many neurodegenerative diseases that have a protein component responsible for pathology are 
termed as proteinopathies. In prion diseases, misfolded proteins have conclusively been 
demonstrated as etiological agent although other protein misfolding diseases such as 
Alzheimer’s, Parkinson’s, Huntington, ALS are actively being investigated for prion-like 
propagation. A prion-like spreading of protein aggregates is emerging as a major 
pathophysiological mechanism in all these diseases but experimental modeling of these slow, 
progressive diseases remains to be addressed. Environmental neurotoxicant exposure has also 
been increasingly recognized as risk factors for these proteinopathies. Although the 
mechanisms underlying this process is poorly understood, prion theory argues that the self-
templating mediated protein misfolding as a unifying denominator in this process. Several 
proteins are involved in this process that is specific for the disease. Therefore, these diseases 
are categorically referred to as Protein Misfolding Disorders (PMD). Organotypic brain slice 
cultures offer advantages over traditional cell culture methods as they resemble the intra-
cerebral environment ex-vivo. The goal of the present study is to establish an organotypic brain 
slice culture model for the investigation of the protein-misfolding mechanisms underlying 
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environmentally linked proteinopathies. We have previously established organotypic slice 
cultures models for sensitive detection in prion disease. Misfolded prions from brain 
homogenates invade and amplify in the slice cultures over a relatively shorter time scale 
compared to animal models. It reduced animal suffering and may be a cost-effective approach 
to study the molecular aspects of these chronic diseases. The ex-vivo nature of these models 
allows easy experimental operation and downstream analysis such as immunohistochemistry, 
and biochemical analysis such as protein and RNA analysis. Several markers are characterized 
by quantitative assessment of the viability of slice cultures (Noraberg et al., 1999). For 
example, propidium iodide (PI) uptake estimates cell death and can be imaged in a live slice 
and further be cultured. Similarly, Lactate dehydrogenase (LDH) efflux allows us to estimate 
the stress from the culture medium. Ordinary Nissl cell staining, Fluoro-Jade (FJ), and 
immunohistochemical staining can be used to assess the integrity of the neuronal cell death. 
Although several cell culture models were available to study the protein misfolding, most of 
these rely on either infecting with a brain homogenate or using protein expression constructs 
with a reporter tags. Cell cultures remain to be a popular method to study the disease process, 
but they suffer from some key limitations. These cells represent an isolated, monoclonal 
population or cells from a mixed origin with no crosstalk to other cell types. However, brain 
slices overcome few limitations such as preserving the have dynamic connections to other cell 
type and maintenance of the electrical activity that is typically present in physiological 
conditions. Organotypic brain slices allow easy experimental access and optimal viability over 
long periods (months). Experiments can be monitored in living slices (e.g., for imaging) during 
the entire culture period. Further, the slices can be fixed and cryosectioned for microscopic 
examination at the experimental endpoint. Different regions of the embryonic brain or spinal 
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tissue can be used in this protocol. Although brain slices are extracted from postnatal day 4 to 
21 pups, blood vessels continue to develop. A transporter protein, GLUT-1 was reported to be 
expressed in blood vessels after 3 days in culture (Camenzind et al., 2010). This suggests that 
endothelial transporters can be functionally maintained in slices that recapitulate blood-brain 
barrier. In this study, we review several applications of organotypic brain slice cultures and 
demonstrate some of their applications such as the effect of the environmental neurotoxicants 
like manganese and lead on protein aggregation. In summary, our results demonstrate the 
organotypic brain slice culture as a flexible model for studying the effects of environmental 
factors on protein misfolding in various proteinopathies of the central nervous system. The 
brain slice culture model will also greatly minimize the animal use for studying 
neurodegenerative diseases. 
Evolution and diverse applications of organotypic brain slice cultures 
The slice culture method was historically introduced by Hogue and colleagues using human 
fetal brain cells in 1947 (Hogue, 1947). However, not until several decades, the roller tube 
method came into existence and later the interface method of culture became popular.  After 
this invention, the interface method became experimentally feasible in several labs and 
optimized for in culture settings in the early 90s. (see review by Stoppini and colleagues) 
(Stoppini et al., 1991). This method of using interests have been applied for testing the long-
term plasticity of neurons (Gähwiler et al., 1997). Organotypic hippocampal slices from 
neonatal mice were prepared and maintained on a porous membrane that drives the nutrient-
rich media through the capillary action from the membrane pores (Stoppini, et al., 1991). Due 
to this simplification step, this method of culturing the brain slices on a liquid-air interface 
became a standard method for slice culture maintenance. The membranes are typically loaded 
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with an insert that allows having an elevation to feed the culture medium from the basal 
chamber of the membrane insert. The slices can be typically cultured on a 30 mm diameter for 
a 6 well plate and with a porosity of 0.4 µM. When the membrane is hydrated, it is transparent 
allowing the bright field and fluorescence microscopy on a live culture. Slice cultures from 
postnatal P8–P10 brains were thought to be best for the brain slice cultures on membrane 
inserts. These slices were shown to have good survival for a prolonged time of several months 
(Marksteiner and Humpel, 2008). Organotypic slice cultures prepared from various brain 
regions such as mesencephalon, striatum, hippocampus, and cerebellum from embryonic (E21) 
to postnatal P7 rats were shown to have good viability when using roller tube technique 
(Ostergaard et al., 1990). Typically, the slices would be cultured for at least ten days to allow 
stabilization of intrinsic projections of the axons in developing slices. Further, this method 
minimizes the endogenous activation and release of signaling molecules such as calcium or 
glutamate, therefore, minimizing reactive astrogliosis. This stabilization period allows the slice 
culture to adhere to the membrane insert and making it flexible for downstream handling such 
as IHC. Slice cultures were prepared from the region encompassing both entorhinal and 
hippocampal regions to determine circuit development in culture. Using biocytin uptake 
labeling, the authors demonstrated the presence of live granule cells and axons of entorhinal 
neurons networking with mossy fibers in the 2-3 week old slice cultures that correspond to the 
development of the rat brain (Diekmann et al., 1994). In addition to neurodegenerative 
diseases, slice cultures have also been used to model cancer. For instance, slice cultures from 
neonatal rats (p2) co-cultured with C6 glioma spheroids to demonstrate the cell migration, 
tumor cell invasion, that mimics the physiological system (Ohnishi et al., 1998). Slices derived 
from mature mice have shown to have poor viability for chronic studies. Therefore, a different 
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study using antisense oligodeoxynucleotides (ASO) against Cx43 gap junctions reportedly 
enhance survival from trauma (Yoon et al., 2010). This ASO treatment caused a transient 
decrease in expression levels of Cx43 gap junctions that lead to survival of neurons with 
normal morphology over a longer culture period. Adult hippocampal slices were maintained 
ex-vivo over 6 days using a medium that closely resembles cerebrospinal fluid (CSF) with 
supplements. The viability of slices was measured using population spike amplitude (PSA). 
Other studies have explored the microenvironment of the tumor using an organotypic slice co-
culture assay for drug testing (Chadwick et al., 2015; Ren et al., 2015). Brain slices co-cultured 
with murine macrophage cell line (RAW 264.7) demonstrated soluble intermediates from HIV-
1 Tat protein are responsible for neurotoxicity in the hippocampal slices (Brana et al., 1999). 
Organotypic slice culture models of Alzheimer's disease (AD) 
Organotypic slice cultures prepared and maintained under low oxygen partial pressure were 
used to model amyloid-beta (1-40) toxicity. Melatonin, the pineal hormone was shown to have 
opposing effects on oxidative stress was observed using slice culture model of AD (Clapp-
Lilly et al., 2001). Low dose reduced the oxidative stress markers based on a reduction in the 
redox-active iron, heme-oxygenase-1 induction and 8-hydroxyguanosine. However, higher 
dose promoted opposite effects. Another study demonstrated neuroprotection by 17beta-
estradiol in the slice cultures via glycogen synthase kinase-3 pathway (GSK-3) inhibition.  
Similarly, cultures prepared form 3xTg-AD mice were used to model Alzheimer's disease that 
recapitulates animal model (Croft et al., 2017). Using slice cultures, a benzothiazole compound 
(BTA-EG4) that binds to amyloid, was shown to reduce tau phosphorylation via GSK-3 
pathway. Similar to Prion infected slice cultures, Another study successfully showed ex-vivo 
replication of amyloid beta in the slices (reviewed in the section below). Using similar strategy 
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aggregation of synthetic Amyloid beta in a long-term hippocampal slice culture supplemented 
with homogenates in the culture media. Further, these amyloid aggregation was concurrent 
with microglial activation, neuronal and spine loss. 
Organotypic slice culture models of Parkinson’s disease (PD) 
Development of dopaminergic neurons was studied using the slices prepared from ventral 
mesencephalon region of neonatal (P1) rats (Holmes et al., 1995). The dopamine neurons, from 
immunoassay by tyrosine hydroxylase were radially grown towards striatal slices but not into 
cerebellar slices when co-cultured. This suggests the nigrostriatal pathway can be oriented in 
slice cultures by guidance and preservation of synaptic connections. Another co-culture system 
using a ventromedial portion of the mesencephalon and striatum was used to evaluate the 1-
benzyl-1,2,3,4-tetrahydroisoquinoline, a PD toxin (Kotake et al., 2003). Olfactory route 
hypothesis has been actively being investigated as an origin site for PD pathology. The rostral 
migratory stream (RMS) in rodents comprises of circuits with direct connectivity from 
subventricular zone (SVZ) neurons that reach the olfactory bulb (OB). Migration of neural 
stem cell precursors but not mesenchymal stem cells was observed when implanted in the 
slices. This was demonstrated using Bromodeoxyuridine (BrdU)-labelling and stem cell 
micrografts into the forebrain slices that help in preserving the rostral part of the lateral 
ventricle, the RMS, and the OB (Tanvig et al., 2009). Therefore, the brain slice cultures 
facilitate neural precursors in a programmable manner. However, modeling stem cells in slice 
culture with pharmacological or genetic manipulation remains to be tested. Toxicological 
modeling of slice cultures is an active area under investigation. As we demonstrate in this 
manuscript, we modeled toxicity studies using the brain slice cultures. Rotenone, a neurotoxin 
is a potent complex I inhibitor of the electron transport chain and used to model dopaminergic 
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and cholinergic neuron toxicity in co-culture brain slices (Ullrich et al., 2009). Rat midbrain 
slice cultures containing substantia nigra (SN) were also used to understand regional 
susceptibility catecholamine neurons suggesting the dorsal tier catecholamine neurons are 
more susceptible (Bywood et al., 2000). Another study utilized th effect of mechanical 
transfection on the nigrostriatal neurons in the slice preparation (Daviaud et al., 2014). 
Progressive loss of dopaminergic cell number created by the lesion was quantified using 
diffusion tensor magnetic resonance imaging suggesting the organotypic slices are a simple 
and rapid method to study dopaminergic neuronal degeneration. Hippocampal slices co-
cultured with microglial cells (primary and n9) to study LPS induced inflammatory responses 
and role of histone deacetylases (Suuronen et al., 2003). In another study, mesenchymal stem 
cell (MSC) were co-cultured with brain slices without direct contact. The MSCs purified using 
fluorescence-activated cell sorting from bulk bone-marrow-cell suspensions. This study 
demonstrated MSC cocultured brain slices have higher BDNF secretion, axonal regrowth and 
shown to support neuronal regeneration in a slice culture model of the mesocortical 
dopaminergic projection system (Sygnecka et al., 2015). 
Organotypic slice culture models of Prion disease 
Prion diseases have prolonged incubation periods making the study of these diseases difficult 
in the lab and considered as biosafety level II or above. Although cells lines were developed 
to maintain infectivity, alternative models that reflect neuropathology remains to be addressed. 
Slice cultures from transgenic mouse were used to determine electrophysiological response in 
the presence or absence of prion protein. Slice cultures were prepared from 19- to 21-day-old 
mice and patch-clamp experiments on the Purkinje cells was performed. Whole-cell recordings 
suggested there is no difference in the resting membrane potential regardless of the genotype 
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of the animal (wild-type mice, tg35, tg20, and Prnp-/- genotypes tested). However, Ca2+ 
activated K+ currents are reduced in Prnp-/- mice are reduced due to an alteration of 
intracellular calcium homeostasis suggesting PrP plays role in depolarization (Herms et al., 
2001). Later, sagittal brain sections were prepared from the cerebellar region of 9-12-day old 
pups and with 350 µm thickness as an ex-vivo prion infective model (Falsig et al., 2008a). The 
prions from infected brain homogenate (RML scrapie) was used to incubate the slices as free 
sections in the physiological buffer. The slices were washed twice and maintained as explants 
on the membrane inserts with culture media supplied. After several days in culture, the slices 
were collected, lysed and treated with proteinase K to digest cellular form of prion protein 
before immunoblotting (Falsig et al., 2008b). The slices gained a proteinase K resistant bands 
that appeared on 21 days post culture and expression increased thereafter. Although the model 
is far superior to existing cell cultures, the proteinase K digestion and western blot requires a 
large amount of protein. Therefore, we developed a sensitive prion detection method using 
real-time quacking induced conversion (RT-QuIC) assay and termed as OSCAR (organotypic 
slice culture assay coupled to RT-QuIC) assay (Kondru et al., 2017a). The advantage of 
OSCAR assay is that it is ultrasensitive and requires a very low amount of slice culture 
homogenate. Further, based on the traces, prion titers can be quantified. OSCAR also offers a 
cost-effective approach to rapidly test the compounds or inhibitors that uncouple prion 
replication and requires less number of animals. We are optimistic that OSCAR model is easy 
to setup and can help several research labs. Prion-infected slices have also been valuable to 
determine temporal alteration in the spine density of Purkinje neuronal cells (Campeau et al., 
2013). Further, this model has been used to explore other 22L prion strains and utilized 
immunohistochemistry for differential staining patterns (Wolf et al., 2015).  
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Organotypic slice culture models of Huntington’s disease and Amyotrophic Lateral 
Sclerosis diseases (HD & ALS) 
HD and ALS are diseases with unique aggregation of either protein/RNA or both as manifested 
diagnostically by expansion repeats typically consisting of PolyQ domains. Organotypic 
striatal slice cultures from neonatal rats were used to model Huntington's disease (HD) 
(Ostergaard et al., 1995). These striatal slices were also demonstrated for the presence of the 
spiny interneurons that are spared in HD and positive for neuropeptides – somatostatin, 
neuropeptide Y and NADPH-diaphorase. These slices were found to be positive for the 
projection neurons that are particularly vulnerable in HD. Analogous to the brain, the slice 
cultures have preserved connections such as the interneurons and projection neurons. In 
contrast, the enkephalin mRNA-containing neurons, which are in-vivo projection neurons, 
were significantly fewer in the cultures. The relative loss of projection neurons and 
preservation of interneurons in single slice cultures of striatal tissue apparently mimic some of 
the neurodegenerative changes of HD. The hippocampal slices prepared from the R6/2 mouse 
as a model for HD. Poly Q aggregates bind to Congo red and chrysamine G that delay 
neuropathology by inhibiting the aggregate formation. Organotypic spinal cord slice cultures 
were also used to study the misfolded superoxide dismutase (SOD1) in relation to 
conformation-dependent strain propagation in ALS models (Ayers et al., 2016). 
Traumatic Brain Injury (TBI) 
Organotypic brain slices have been utilized to model and understand the traumatic brain injury 
(TBI). The major disadvantage of using these models are associated with difficulty in method 
setup for a controlled and reproducible damage. While brain slices provide a controllable 
environment for the accurate delivery, of the specific cellular trauma as a result of various 
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methods remains to be investigated. One study produced traumatic injury utilizing mechanical 
sheer created by rolling a steel cylinder on the slices. Next, a second injury was created in a 
small area of the slice. These two forces were created to imitate the head injury and hypoxic 
damage that results as a post-traumatic event such as hypoxia or swelling (Adamchik et al., 
2000). Similarly, using mechanical injury on rat brain slices, disruption of calcium homeostasis 
and associated apoptosis was demonstrated (Morrison et al., 2000). Using deformable silicone 
membranes, a two-dimensional stretch of organotypic hippocampal slice cultures was used to 
create acute phases of TBI (Morrison et al., 2006). We have taken a novel approach to study 
the TBI. In this manuscript, we demonstrated a novel in-vivo model of blast injury, followed 
by ex-vivo electrophysiological assessment using a multi-electrode array, as described in the 
results section. 
Results 
Progressive toxicant-induced cell death in organotypic slice cultures  
Organotypic cerebellar slice cultures were prepared from 10-12-day old pups and cultured for 
21 days post-infection (dpi) for the adaption in ex-vivo. These slices were exposed to 100 µm 
Manganese (Mn) for different time points. The slice cultures were measured for the viability 
using Propidium Iodide (PI) incorporation and Annexin V staining. PI stains the dead cells 
when the cell membrane is compromised. Mn increased the PI uptake in the slices in a time-
dependent manner and the fluorescence intensity was quantified (Fig 1A). Although Mn 
treatment caused an increase in the fluorescence intensity as early at 24 and 48 hours post-
treatment, it is not significantly different from controls. However, Chronic exposure of Mn to 
the slice cultures (5 and 7 days post-treatment) caused a significant increase in the PI update. 
Next, we evaluated the apoptotic population and cell viability based on Annexin V staining 
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(Fig 1B). The slices demonstrated to have remarkable viability with over 95% of the cells 
remain viable. Mn treatment for 24 and 48 hours post-treatment showed a slight decrease in 
the viability of the slices with a marginal increase in late apoptotic cells when compared to 
controls. The quantification of the cell populations in either early apoptosis or late apoptosis 
were shown in (Fig 1C) whereas the distribution of the cells in each quadrant as shown in (Fig 
1D). The right quadrants contain the apoptotic cells while the bottom left quadrant consists of 
live cells. These results demonstrate using flow cytometry and imaging to accurately quantify 
the viability of the cells in the slice cultures.  
Measuring cytokine response from the slice cultures 
Slice cultures are exposed to toxicants (MPP+, 6-OHDA, and Manganese) and the stress-
induced cytokine release was measured using Luminex assay. We measured the following 
cytokines IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 and TNFα (Fig 2 A-I). 6-OHDA 
and Mn have significantly increased the cytokine release from the slice cultures. Mn was able 
to elicit the significantly higher release of IL-6 and TNFα when exposed for the chronic 
duration (96 hr) when compared to a shorter time of 24 hrs. However, the other cytokines tend 
to be higher at 24-hour time points. However, the cytokine, IL-4 change is not statistically 
different between controls and treatments. 
2. Ectopic gene delivery in organotypic brain slice cultures 
Slice cultures have unique advantage of desired protein to be expressed for long term studies. 
We prepared from the brain slices from cerebellar region and mounted on the inserts for 
transduced with an adeno-associated virus (AAV). The AAV virus used had green fluorescent 
protein (GFP) reporter tag that will allow live imaging in real time. After the slices were 
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infected, the slices were maintained for several dpi for imaging at various time points. The 
expression of the GFP was live imaged at 7 dpi using a fluorescent microscope (Fig 3A-B). 
The slices demonstrate excellent transduction efficiency with a clear expression of GFP 
starting from 2 dpi while the intensity continued to increase up to 7 dpi and then peak 
fluorescence plateaued (data not shown). Further, the virus serotypes AAV 2 and AAV 5 
demonstrated tropism for Purkinje cells. Next, we infected the slice cultures from different 
brain region to determine the transduction efficiency. The cortico-striatal slices were infected 
with AAV 5 and imaged at 7 dpi (Fig 3C-D) at a lower magnification (2x) was shown to 
visualize the entire right hemisphere. Similarly, the cerebellar slices, the cortico-striatal slice 
cultures are readily transduced with AAVs. A magnified image (20x) of the striatal region of 
the slice was shown (Fig 3E). Further, we tested whether lipophilic gene transfection agents 
lipofectamine2000 to express GFP containing plasmid (data not presented). Although there is 
a low population of cells that express GFP, this method is not as efficient as the viral 
transduction for gene delivery in slice cultures. 
 
Immunohistochemistry in slice cultures to evaluate the morphology and 
neurodegeneration  
Slices can be imaged either live using viable antibodies or can be fixed and stained as free-
floating sections. Various markers for different cells types can be used as in traditional 
histochemistry. In Fig.4, we demonstrate the neurodegeneration as a result of toxicants Mn and 
Cu on the slice cultures. Cu caused loss of neurites and disruption in the tau protein levels that 
is crucial for the integrity of the microtubules. While Mn also caused loss of Tau protein, the 
effects are not as severe when compared to Cu. Confocal imaging demonstrates a severe loss 
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of dendrites as evident in Purkinje cell layer as sustained by calbindin antibody and the 
microtubule binding protein Tau is shown in red stain.  
Micro-electrode array for electrical activity in the slice cultures -Modeling TBI   
Multichannel Systems (Reutlingen, Germany) MEA2100 in vitro recording system with built-
in amplifier, a stimulus generator, temperature control, and perforated 60-electrode arrays that 
allow slices to be continuously perfused top-to-bottom with oxygenated artificial cerebrospinal 
fluid buffer. In an ongoing study, we are exploring the neurophysiological consequences of 
mild traumatic brain injuries (mTBI) induced by compressed gas-driven, primary shock waves 
(Fig. 4). In this study, the recording from the hippocampal CA1 region (Fig 4A-C) and the 
medial prefrontal cortex (mPFC, Fig. 4D) is shown. The slices were prepared as 400-µm 
coronal brain slices harvested from wild-type C57BL mice sacrificed 30 days post-blast (n=10 
animals/group). Using this system, we have been able to capture bilateral recordings for both 
brain regions from either side of each coronal slice’s midline. We are examining both 
spontaneous spike rates and micro-stimulus-evoked spike activity. Although spike sorting and 
unit discrimination can be quantified similarly for any other model, our results suggest that the 
spontaneous spike activity may differ between TBI and sham-TBI mice. 
Discussion 
Organotypic brain slices derived from CNS tissue maintains homeostasis due to a network of 
glial and neuronal connections. Therefore, the CNS resident cells such as glia produce 
cytokines and other factors in response to an external stimulus or toxicant exposure. In addition 
to the connectivity, the slices are physiologically respond based on the electrical activity. The 
ex-vivo nature of these slices allows us to interrogate the experimental question at any point in 
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the culture period and help us easily integrate with other culture protocols. The components 
released from these slices can be harvested in real time from the spent culture media. Therefore, 
the organotypic slice culture model remains to be invaluable for studying the role of toxicants 
in biologically relevant and alternative models of toxicology. Slice cultures demonstrate Mn 
toxicity as early as 24 hours based on the viability and PI incorporation. However, there is a 
significant effect on viability only after long-term exposure (i.e.., 5 days). The serum from 
culture media could potentially attenuate the toxicant effects of low concentration of 
Manganese. However, prolonged Mn treatment caused a significant reduction of viability as 
evident by the increase in the PI uptake and Annexin V correlated with the toxicity. In addition 
to neurotoxicological studies, the slice cultures have a unique advantage to study genetic 
engineering for evaluating the role of a specific gene of interest. Previous studies used 
electroporation to express protein-coding DNA (plasmid) delivery in slices generated from 
embryonic pups at a specific area on the slice. The inconsistency in delivering the electric 
currents and targeting a broader area remains to be a concern using this method. Our method 
demonstrated using Adeno Associated Virus (AAV) for effective gene delivery. It overcomes 
the physical trauma to the slices as induced by electric current. Using AAV 2 and 5 serotypes, 
we demonstrated that these AAVs have preferential tropism for Purkinje neurons in cerebellum 
and neuronal population in cortico-striatal regions in the organotypic slice cultures. The intact 
slices attached to the membrane insert are processed without dislodging the slice off the 
membrane. This helps to preserve the structural integrity of the slices during experimental and 
post-fix processing and thus allow for in-situ imaging. For the electrophysiological studies, we 
used multielectrode array either from organotypic slices or acute slices after treating the mice. 
Using acute slices, multi-unit spontaneous firing rates of the thalamic reticular nucleus (TRN), 
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and evoked potentials were quantified. The evoked potentials are generated via micro 
stimulation through one or more electrodes underlying the adjacent internal capsule. The mice 
subjected to TBI showed a decrease in the spike firing rate in the medial prefrontal cortex. 
Taken together, we have reviewed the current state of the art applications of the slice cultures 
and established the organotypic ex-vivo slice culture model for studying neurotoxicology and 
disease modeling.  
Methods:  
Organotypic slice cultures: All the experiments involving animal protocols were approved 
by Iowa State University’s Institutional Animal Care and Use Committee (IACUC). 
Organotypic slices were prepared as previously described from 9- to 12-day-old mouse pups 
(Kondru, et al., 2017a). After dissecting the brain, it was oriented in the sagittal or coronal 
plane in the Compresstome’s specimen tube. 2% low-melting-point agarose was poured 
maintaining proper orientation and quickly solidified by chilling specimen tube. To maintain 
the brain slices, ice-cold Gey’s balanced salt solution supplemented with the excitotoxic 
antagonist, kynurenic acid (GBSSK) was used. The brain slices were sectioned at 350-μm thick 
slices using medium settings. The slices were plated on Millicell inserts in a 6-well plate 
supplemented with slice culture media in a humidified atmosphere of 5% CO2 at 37 °C. Slices 
were cultured for 1 week before exogenous expression of genes. For transfection, 
lipofectamine 2000 was used. The 1 µg of plasmid was mixed with 10 µl of lipofectamine and 
total volume was made to 50 µl and used to transfect 5 cerebellar slices. For transduction, AAV 
virus expressing a GFP reporter was mixed with opti-MEM in equal volume and used to 
directly as a micro drop on the slice. After transduction, the slices were cultured for at least 3 
days before imaging as evident for GFP expression that peaked after 7 days.  
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Multiplex Luminex immunoassays Cytokine release: 
Cytokine release was measured using the Luminex immunoassay as described previously 
(Gordon et al., 2011). A mixed panel of cytokines relevant for neuroinflammation as described 
previously were used and quantified with recombinant standards. Media from slice cultures 
were frozen until assayed for cytokines.  
Ex-vivo MEA analyses of brain slices from mice: 
Mice were decapitated after being anesthetized with 4% isoflurane in 2 L/min O2 for 90 sec. 
The extracted brain is sliced at 400 µm on a vibratome while immersed in ice-cold 
carbogenated sucrose cutting solution. Slices are stored in ice-cold carbogenated sucrose 
cutting solution until all slicing is completed. All slices were then incubated 30-min at 32C in 
a holding tray of carbogenated normal artificial CSF (aCSF) recording solution before the 
holding tray is transferred to the bench at RT. We used a 60-channel perforated multi-electrode 
array (MCS model 60pMEA100/30iR-Ti-gr) with a 30-µm electrode diameter and an inter-
electrode distance of 100-µm (10 x 6 electrode array is 0.93 x 0.53 mm). Preparation of the 
MEA recording session was done as described previously with modification (2014). The slices 
are set up on the stage of an inverted microscope (Nikon TE2000-U, Tokyo, Japan) equipped 
with a 4X objective to aid slice orientation and imaging of the MEA-slice preparation. Slice 
recordings will be made in carbogenated normal aCSF recording solution heated to 32C and 
continuously exchanged at 2 mL/min, while the slice tissue itself will be perfused at 0.1 
mL/min through the bottom of the array chamber. This slow vertical perfusion through the 
MEA increases adherence between the slice and electrodes and gets carbogenated aCSF to the 
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bottom of the slice at the neuronal-electrode interface. After at least 5 min, spontaneous action 
potential discharge activity was recorded for 2 min at a sampling rate of 25 kHz from which 
we will be able to determine the neuronal firing pattern or neuronal oscillation synchrony of 
the TRN. After recording spontaneous activity, we performed high-frequency stimulation 
(HFS: 120 Hz, 140 µA) and low-frequency stimulation (LFS: 1 Hz, 140 µA) to determine their 
effect on neuronal firing pattern or on neuronal oscillation synchrony (Anderson et al., 2003; 
Fuentealba et al., 2005). For stimulus-evoked activity, a 2-min baseline was recorded followed 
by a 2-min post-stimulus recording. Raw, unfiltered data streams were captured for data 
processing and multi-unit sorting and discrimination was conducted on bandpass-filtered data 
(300 Hz – 3 kHz). 
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Figure 1: Characterization of organotypic slice cultures for the viability 
(A) Characterization of toxicant-induced cell death in slice cultures. Dose-response 
relationship between increasing exposure time to Manganese (Mn) and cellular propidium 
iodide (PI) uptake, measured for the cerebellar slice cultures. There significant increase in PI 
uptake is noticed after 5 and 7 days post exposure (dpe) (B) Quantification of % live cells as 
evident by AnnexinV staining and flowcytometry of slice cultures after exposure. Viability 
drops down at 5 dpe and continues to decrease upon 7 dpe. (C) Data are shown as means ± 
SEM, as compared with control cerebellar slices (n = 3).  and *p < 0.05 using one-way 
ANOVA with Bonferroni posttest. (D) Flowcytometric representation of Annexin V staining 








Figure 2: Secretion of cytokines in response neurotoxicants, MPP+, 6 OHDA, Mn (both 
short-term and long-term exposure):  
Cytokines production in the organotypic slice cultures were quantified from spent culture 
media using Multiplex bead-based Luminex assay system. A panel of known proinflammatory 
cytokines was used. A significant increase in the pro-inflammatory cytokines was observed in 
Mn and 6-OHDA treatments (IFNγ, IL-1β, IL-2, IL-5, IL-10, IL-12) and A dose-dependent 
increase of TNFα and IL-6 was observed. Data represented as the group mean ± SEM (n = 3–
4 per group). Asterisks (***p<0.001, **p<0.01 and *p<0.05) indicate significant differences 





































































































































































































































































































































Figure 3: AAV virus-mediated transduction for targeted gene delivery 
(A) Cerebellar slices- a schematic showing cerebellar folia with granular layer and Purkinje 
border highlighted in the rectangular box.  (Source; mouse brain atlas). AAV virus with a GFP 
reporter was diluted in opti-MEM and Slices were transduced by placing a microdrop (2uL/ 
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cerebellar slice and 4 ul for corticostriatal slices on the dorsal surface of the slice. The liquid 
spreads across the surface owing to surface tension. The media was replaced with fresh culture 
media and slices were incubated for 5-7 days for live imaging. (B) Bright GFP expression in a 
Purkinje layer with a dense network of dendrites is shown. Scale bar 25µ. (C) Cortico-striatal 
slices used to transduce with GFP-AAV - schematic showing a slice with cortical and striatal 
region distinction cultured similarly as described for a cerebellar slice.  The highlighted portion 
(right half) was imaged. (D) The low magnification demonstrates efficient transduction in 
cortico-striatal slice cultures as evident by the GFP expression (green) is observed throughout 
the slice culture. (E) A higher magnification (20x) image was shown to specify neuronal 








Figure 4: Immunohistochemistry of organotypic slice cultures 
Slices were exposed to neurotoxicants, Manganese (Mn) 100 uM and Copper (Cu) 1uM for 24 
hours, fixed and immunostaining and confocal imaging was performed. Slices were stained 
with Hoechst for nuclear staining, Calbindin for Purkinje neurites and Tau protein to stain for 
microtubule integrity. As evident by Red stain, partial loss of Tau protein was noticed in slices 
treated with Mn and profound loss of Tau immunoreactivity was evident with Cu treatment. 





Figure 5: Extracellular recording of the mouse brain slices  
(A) Using a micro-electrode array of 60 (10 x 6), 30-µm electrodes spaced 100 µm apart. Slice 
was positioned over electrodes to record from CA1 region. High-frequency stimulation (C, red 
rectangle) was delivered through one electrode (B, black dot) in the proximity of Schaffer 
collaterals after recording a 1-min baseline, which triggered a wave of activity across CA1 as 
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exemplified by one representative unit (B, red dot).  The same MEA was also used to compare 
the spontaneous spike rate of the medial prefrontal cortex (D-E) in mice whose right side of 
the head was facing compressed gas blast-induced shock wave. (F) Spike firing rate was 
quantified and plotted to compare Sham and TBI. The spike firing rate was lower in the animals 
exposed to blat when compared to controls. (G) Spontaneous activity patterns in organotypic 
slice cultures. Cerebellar slices were cultured for 21 days on a membrane insert and transferred 
to a multi-electrode chamber, to observe the spontaneous firing activity from the slice. Firing 
patterns from two electrodes (#41 and 42) were presented for comparison.  
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Abstract  
Protein misfolding is a key pathological event in neurodegenerative diseases like prion 
diseases, synucleinopathies, and tauopathies that are collectively termed protein misfolding 
disorders. Prions are a prototypic model to study protein aggregation biology and therapeutic 
development. Attempts to develop anti-prion therapeutics have been impeded by the lack of 
screening models that faithfully replicate prion diseases and the lack of rapid, sensitive 
biological screening systems. Therefore, a sensitive model encompassing prion replication and 
neurotoxicity would be indispensable to the pursuit of intervention strategies. We present an 
ultra-sensitive screening system coupled to an ex vivo prion organotypic slice culture model to 
rapidly advance rationale-based high-throughput therapeutic strategies. This hybrid 
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Organotypic Slice Culture Assay coupled with RT-QuIC (OSCAR) permits sensitive, specific 
and quantitative detection of prions from an infectious slice culture model in a reduced time 
scale. We demonstrate that the anti-prion activity of test compounds can be readily resolved 
based on the power and kinetics of seeding activity in the OSCAR screening platform and that 
the prions generated in slice cultures are biologically active. Collectively, our results imply 
that OSCAR is a robust model of prion diseases that offers a promising platform for 
understanding prion proteinopathies and advancing anti-prion therapeutics. 
Introduction  
Prion diseases, or transmissible spongiform encephalopathies (TSEs), are chronic, 
lethal neurodegenerative disorders affecting both humans and animals, and a cure for these 
devastating brain diseases has yet to be identified. The common prion diseases of animals 
include bovine spongiform encephalopathy (BSE) in cattle, scrapie in sheep and goats, and 
chronic wasting disease (CWD) in cervids. Major human prion diseases are Creutzfeldt-Jakob 
disease (CJD), Gerstmann–Sträussler–Scheinker syndrome (GSS) and fatal familial insomnia 
(FFI)(Prusiner, 1998). Prion diseases are often hard to detect due to their long incubation 
periods as well as clinical presentations that overlap with other neurological disorders. In 
addition to classical prion diseases, emerging evidence suggests that other protein misfolding 
disorders (PMDs) like Parkinson’s disease (PD) and multiple systems atrophy (MSA) have 
misfolded α-synuclein proteins that are experimentally transmissible(Bernis et al., 2015; 
Prusiner et al., 2015) and other PMDs like Alzheimer’s, FTDs, Huntington's etc., also have 
unique amyloids capable of prion-like aggregation and experimental propagation(Jaunmuktane 
et al., 2015),(Brundin et al., 2010). The normal cellular form of prion protein (PrPC) is richly 
distributed throughout the nervous system and lymphoid tissues. PrPC is known to play a role 
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in oxidative stress, apoptotic signaling, and other biological functions including interactions 
with metals(Anantharam et al., 2008; Choi et al., 2010; Harischandra et al., 2014). Although 
the mechanisms underlying the templated conversion of PrPC into its misfolded isomer, PrPSc  
(Sc denotes scrapie; also referred to as PrPres for protease-resistance), remains poorly 
understood, PrPSc associated with TSEs are oligomers, fibrils or aggregates that contribute to 
neuropathological processes(Solomon et al., 2010). 
Detection of misfolded prion in a high-throughput format is necessary for rational 
therapeutic designs(Karapetyan et al., 2013; Mallucci et al., 2005). Currently, mouse bioassays 
serve as a predominant method of assessment for prion infectivity. However, these models 
present several obstacles to developing high-throughput assays. For instance, incubation times 
can extend to excessively long durations and clinical signs are typically not manifested until 
the terminal stages of infection(Harischandra, et al., 2014). Furthermore, working with infected 
animals raises concerns about occupational safety and the increasing costs associated with care 
and management of laboratory animals(Falsig, et al., 2008b; Martin et al., 2011). Efforts to 
establish in vitro models of prion diseases met with limited success due to the inability of cells 
to maintain persistent infectivity over time. Results generated from one or two cell models has 
not readily translated to other preclinical and clinical models of different prion strains of 
animals and human prions(Giles et al., 2016; Giles et al., 2015). Notably, in vitro cell models 
fail to recapitulate the neuropathological features of prion disease. Thus, a suitable alternative 
to chronically infected animal models could help advance prion research via rapid validation 
of therapeutic options.  
The recently developed real-time quaking-induced conversion (RT-QuIC) assay for 
prions is gaining wide acceptance for its ultra-sensitive detection of prions from a variety of 
39 
samples and has the potential to become a rapid and sensitive prion detection assay. This robust 
and reproducible, high-throughput prion detection assay can be adapted for both animal and 
human prion diseases, and it is compatible with a wide range of prion strains, allowing strain 
discrimination(Cramm et al., 2015a; Cramm et al., 2015b; Henderson et al., 2013; McGuire et 
al., 2012; Orru et al., 2014). Notably, RT-QuIC was shown to detect prions with a million-fold 
greater sensitivity than had been achieved via the immunoblot detection of scrapie prions(Shi 
et al., 2013) and also with superior specificity, stability, and reproducibility(Cramm, et al., 
2015a) for diagnostic screening. This assay also was adopted for quantitative and qualitative 
estimation of prion titers in samples using endpoint titration of prions defined by seeding 
activity(Henderson et al., 2015; Wilham et al., 2010). Thus, we postulated that integrating the 
Organotypic Slice Culture Assay with RT-QuIC (OSCAR) would prove to be the ideal 
platform for fulfilling a long-standing gap in the translational arena of prion diseases. Herein, 
we show that OSCAR is a rapid, specific and quantitative method that can be readily adopted 
for translational research and for understanding the molecular mechanisms underlying protein 
misfolding disease processes.  
Results 
Ex vivo cerebellar slice cultures exhibit hallmarks of prion infection and 
neurodegeneration.  
To test whether organotypic slices accumulate PK-resistant prions, the molecular hallmark of 
prion infection in culture, we prepared organotypic cerebellar slices from 9- to 12-day-old WT 
pups and maintained them as ex vivo slice cultures after infecting them with RML scrapie. 
After five weeks in culture, slices were harvested, and lysates were digested with Proteinase-
K for the electrophoresis profile. The slices infected with RML scrapie show an obvious pattern 
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of di-, mono-, and non-glycosylated PK-resistant bands (PrPSc) on immunoblots with bands 
shifted lower than those from uninfected slices (Fig. 1A). This illustrates that the resulting PK-
resistant fragments have lower molecular weight when compared to the undigested protein. 
This banding profile is consistent with the terminally sick brain homogenates of mice (Fig. 
1B), indicating the amplification of prions in culture. Next, we evaluated slice viability using 
propidium iodide (PI) staining. The slice cultures showed significantly less PI-positive staining 
during the culture periods (<5%) tested up to 9 weeks when compared to a positive control 
(Sup Fig. 1). However, after 42 days in culture, slices infected and cultured with RML scrapie 
showed a significant increase in PI-positive cells, concentrated in the granular cell layer when 
compared to slices treated with NBH (Fig. 1C-D). Next, we examined the neuronal density of 
NeuN+ cells in the slices. RML scrapie-infected slices displayed a significant neuronal loss in 
the granular layer of the cerebellum when compared to non-infectious brain homogenate 
(NBH)-treated slices after 42 dpi (Fig. 1E and 1F). Furthermore, we characterized pro-
apoptotic markers in RML-infected cerebellar slice cultures. A pro-apoptotic signaling cascade 
in RML scrapie-infected slices was evidenced by caspase-3 activation and a significant 
increase in the novel protein kinase C isoform δ (PKCδ) and its cleaved fragment (Fig. 1G, full 
blots in Sup Fig. 5). Taken together, these results suggest that slices cultures serve as a 
representative model for prion replication and neurotoxicity in a culture environment while 
preserving the complex connections.  
RT-QuIC assay provides a versatile platform for sensitive detection of prions in ex vivo 
slice cultures. 
Following the establishment of mouse organotypic cerebellar slices cultured ex vivo, we 
evaluated the RT-QuIC assay for testing nanogram to femtogram quantities of misfolded 
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prions in slice cultures. Only the scrapie-infected slices and terminally sick mouse brain 
homogenates (positive control) were amplified consistently across multiple experiments 
(n>20), whereas NBH-treated slices or healthy mouse brain homogenates did not show seeded 
amplification over the course of 72 h of reaction (Fig. 2A). To confirm that this amplification 
occurred due to specific amplification of prions in slice cultures, we used transgenic prion 
mouse models to probe for prion seeding activity. We prepared slices from Tga20 pups that 
overexpress prion protein ~10 fold and/or PrP-/- pups with no PrP expression, infected them 
with either RML scrapie or mock normal brain homogenates and cultured them for 28 days 
before subjecting their samples to RT-QuIC assay. Only slices from Tga20 mice showed 
seeding activity (Fig. 2B), whereas NBH-treated slices or PrP -/- slices infected with RML 
scrapie did not show any seeding activity at any of the dilutions tested (Fig. 2C). The 
amplification kinetics from Tga20 slices were seed dose-dependent as demonstrated by the 
time required to reach threshold and maximum average fluorescence readings (Fig. 2 D-E). 
Collectively, these findings suggest that true prion replication in organotypic slice cultures and 
the seeding activity is governed by the expression of cellular prion protein.  
Kinetics of prion augmentation in slice cultures. 
We systematically characterized the seeding activity of misfolded prion following various dose 
and incubation times. The seeding activity in RT-QuIC assays of samples from organotypic 
slice cultures became progressively stronger as culture duration increased. Cultured slices 
infected with NBH or RML scrapie were harvested at multiple time points ranging from 1 to 
42 dpi for RT-QuIC assay. Seeding activity was detected as early as 7 dpi (Fig. 3A). However, 
seeding activity increased substantially in RT-QuIC assays only after 14 dpi when PrPSc started 
to buildup. This is comparable with previous reports demonstrating PK-resistant material 
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deposition only after two weeks in RML scrapie-infected slices(Aguzzi et al., 2012; Campeau, 
et al., 2013; Falsig, et al., 2008b). Nonetheless, slices harvested at 21 dpi showed even stronger 
seeding activity, and the seeding activity in RT-QuIC assays did not peak until around 42 dpi 
(Fig. 3A). The slices harvested immediately after starting the culture (1 dpi) did not show 
discernible seeding activity, suggesting that the seeding activity did not begin from the 
inoculum used to infect slices. This time-dependent intensification of seeding activity in RT-
QuIC assays (Fig. 3A) clearly suggests the amplification of prions in the ex vivo cultured slices. 
To further determine the seeding efficiency of prions replicated in slice cultures at various time 
points after infection and culture (7, 14, 21, 35 and 42 dpi), we tested serial 10-fold dilutions 
of slice culture homogenates (5 ng - 50 fg) (Fig. 3B-F). Slices cultured for 42 and 35 dpi (Fig. 
3B and 3C respectively) showed greater seeding activity and had both shorter lag phases and 
stronger relative fluorescence (RFU) values compared to 21 dpi (Fig. 3D). The seeding activity 
of prion-infected slice cultures at 14 dpi and 7 dpi was not as robust as at 21 dpi (Fig. 3E-F). 
Additionally, the slices harvested after 7 and 14 dpi took longer to reach thresholds and the 
average RFU was reduced 2- to 3-fold with respect to 35-dpi cultures. Furthermore, the ThT 
fluorescence intensity generated from the RT-QuIC seeds was correlated (r=0.855) with time 
spent in culture (Sup Fig. 2). These results clearly demonstrate that RT-QuIC captures both 
amount and rate of prion infection in the ex vivo brain culture model.  
Quantitative estimation of infectious titers from prion-infected slice cultures based on 
seeding activity in RT-QuIC assay. 
Quantifying the seeding activity of slice cultures would help us to understand the kinetics and 
dynamics of prion aggregation, which would further aid in developing disease-modifying 
therapies or improving existing compounds. To quantify prion seeding activity, we tested 
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endpoint seeding dilutions of slice cultures as described in previous reports using the 
Spearman-Kärber approach for calculating the 50% infective dose (ID50) in virus titration 
experiments(Wilham, et al., 2010). We performed RT-QuIC assays on log dilutions (10 fold) 
of slice homogenates (as shown in figures 3B-F) to determine the seeding activity of different 
dilutions at each endpoint. The Spearman-Kärber method relies on the number of wells turning 
positive at each dilution point to determine arbitrary SD50 (seeding activity, 50%) values, 
representing the dilutions of slice homogenate at which 50% of the wells became positive in 
RT-QuIC reactions. Over a wide range of time points, SD50s showed a clear pattern of 
increasing values with increasing culture durations for homogenates from both WT and Tga20 
organotypic brain slices (Fig. 4A). In addition, the seeding activity for Tga20 slice cultures 
was always higher at all time points tested possibly due to a higher quantity of seeding prions. 
The average values (SD50/g) obtained by this method peaked at 35 dpi for both WT slices (6.32 
X 109) and for Tga20 slice cultures (3.64 X 1010). Serial dilutions of RML scrapie brain 
homogenates that were used to calculate SD50 achieved a similar seeding activity per 
gram(Wilham, et al., 2010), suggesting that the prion titers accumulated in cultured slices were 
comparable to in vivo conditions (Sup Fig. 3). Next, we explored the threshold-crossing time 
(Tt), which is the time taken for the fluorescence intensity to cross the threshold, as a measure 
of seeding power of sample tested, as described in previously published reports, to indirectly 
calculate the amyloid formation rate (AFR), which is the inverse of Tt (in hours). To gain a 
comprehensive understanding of prion replication, we used this model to study the kinetics of 
amyloid formation based on Tt derived from different seeding dilutions (50 fg- 5 ng) of slice 
culture homogenates at 7-42 dpi (Fig. 4B). Not only was AFR correlated with the dpi of 
cultured slices, but also higher seed concentrations were directly proportional to AFR. The 
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lower dilutions that never turned positive in an RT-QuIC assay were predictably considered to 
have zero AFR. In addition to this, PrP immunoreactivity was examined semi-quantitatively 
using dot blot assay (as described in methods). Homogenates prepared from slices cultured 1-
42 dpi (0.5 µg and 5 µg) were transferred to nitrocellulose membrane and treated with the prion 
antibody POM1 to visualize PrP immunoreactivity. The signal intensity of PrP, normalized to 
the loading control β-actin, increased in a time-dependent fashion (Fig. 4C-D). These results 
demonstrate that the OSCAR platform enables us to quantify the progressive increase in 
amyloid formation rate and determine the prion titers from cultured slices. This is 
advantageous when determining the effect of pharmacological modulators on amyloid 
formation as an indirect marker of disease progression under in vivo conditions. 
Effect of anti-prion compounds on seeding activity in RT-QuIC assay of prion-infected 
slice cultures. 
To extend the applicability of our OSCAR model, we applied some already known anti-prion 
compounds (astemizole, Congo red and quinacrine) to slice cultures to test their ability to 
influence the seeding activity of prions from RML scrapie-infected slice cultures. First, we 
measured the seeding ability of slice cultures tested in two independent experiments with high 
reproducibility (Sup Fig. 4). Next, we compared the seeding ability of the slice cultures treated 
with compounds at various dilutions (Fig. 5A-C). Both Congo red and quinacrine, but not 
astemizole, showed reduced seeding activity at 5 ng (Fig. 5A) and 0.5 ng (Fig. 5B) seed 
concentrations. Similarly, when a dilution of 50 pg was used as seed, both Congo red and 
quinacrine, but not astemizole, completely inhibited seeding activity (Fig. 5C). Quantification 
of percent positive wells tested for each treatment shows a clear pattern of seeding activity for 
the compounds (Fig. 5D). Anti-prion activity was clearly manifested by a reduction in AFR 
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(Fig. 5E) for two of the compounds. Together, these results suggest a true reduction in seeding 
activity upon addition of the anti-prion compounds Congo red and quinacrine. Furthermore, 
these results highlight the utility of the OSCAR model for determining the preclinical efficacy 
of compounds that are effective against prion seeding activity. 
Serial propagation of prions and utility of non-cerebellar brain slice cultures to confirm 
prion infectivity. 
To assess the infectivity of the prions generated in slice cultures, we tested the ability of 
homogenates prepared from RML scrapie-infected brain slice cultures (P1) to infect cerebellar 
slices (P2) that had been cultured uninfected in parallel with the infected batch. Slices were 
cultured for 30 days with log dilutions ranging from (0.5 ng – 50 fg) before testing via RT-
QuIC assay. Both P1 and P2 slice cultures demonstrated comparable seeding activity at the 
dilutions shown (Fig. 6A). The use of cerebellar regions alone required a large number of pups 
for the study. Thus, to expand the number of slice cultures prepared from a given number of 
pups, we next tested whether other brain regions can be adopted for an organotypic culture 
model of prion infection. We infected and cultured non-cerebellar brain sections 
(corticostriatal slices) for 42 days before testing for seeding activity. To our surprise, these 
slices demonstrated excellent seeding congruent with the seeding activity obtained from 
cerebellar slice cultures (Fig. 6B), with seeded amplification occurring in a concentration-
dependent manner across a high dynamic range (50 ng to 50 fg) of seed concentrations. 
Together, these results show the versatility and utility of OSCAR as a rapid bioassay for prion 





We developed a versatile system for quantifying prion seeding activity known as OSCAR that 
uses the RT-QuIC assay to detect prions in organotypic slice cultures. It is imperative to 
develop such integrated models for drug development against chronic neurodegenerative 
conditions like prions and related protein misfolding diseases that can remain asymptomatic 
for several years. The OSCAR model could advance the utility of the prion organotypic slice 
culture assay (POSCA) for this infectious disease (Falsig, et al., 2008a) However, the caveat 
for both approaches is that they require adequate technical expertise to prepare and long-term 
maintenance of the cultures. Nevertheless, we demonstrate the efficacy of prion-infected 
.organotypic slice cultures coupled with seeding assays like RT-QuIC to quantify seeding 
prions generated in the cultures in a more cost-effective way. Among various in vitro culture 
models, the major advantage of organotypic slice culture is that it preserves morphologic 
architecture and physiologic interconnectivity between various cell types like neurons and 
neuroglia. In addition, chronic animal distress associated with in vivo prion infection would be 
circumvented while permitting continuous access to brain tissue for experimental procedures 
throughout the course of infection. The slices were maintained in culture for several weeks 
with good viability. Slices infected with scrapie accumulated PK-resistant prions in culture 
while demonstrating neurotoxicity (Fig. 1A-G) consistent with previous reports(Aguzzi, et al., 
2012; Campeau, et al., 2013; Falsig, et al., 2008b; Harischandra, et al., 2014). We found the 
RT-QuIC assay amplifies prions from minute quantities of protein extracted from slice cultures 
in both a seed concentration- and culture time-dependent manner (Fig. 3A-E) and can be 
quantified based on seeding characteristics (Fig. 4A-B). Importantly, prion knockout slices 
infected with RML scrapie did not show any seeding activity across a wide range of seed 
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dilutions (Fig. 2C). The level of seeding activity sustained in our WT slice cultures increased 
with the duration of the culture period and is comparable to published values(Falsig, et al., 
2008b). Indeed, the seeding activity that we detected as early as 7 dpi was unexpected, 
suggesting that the OSCAR model is more sensitive than the prevailing methods of detecting 
infectivity such as Western blots. This rapid amplification is relevant to recent discoveries that 
the replication of PrPSc was observed in vasculature very early after microinjecting prions into 
mouse brains(Chesebro et al., 2015). Furthermore, the inoculum used was not detectable in 1-
dpi slices possibly due to 1) the washing steps involved in culturing the slices and 2) the 
homogenized slices were further diluted before testing.   
We demonstrated the sensitivity of detecting prions with our OSCAR model of ex vivo prion 
infection and characterized the kinetics of prion amplification at various time points in culture 
(Fig. 3). The time course of prion amplification in slice cultures is analogous to the kinetic 
pattern of in vivo bioassays as PK-resistant prions rapidly reach maximum titer towards the 
terminal stage of infection, which becomes accelerated in the ex vivo preparation. Based on 
multiple endpoint titrations for RML scrapie prions in slice culture, seeding activity shows a 
progressive and time-dependent amplification. The SD50 values derived from the Spearman-
Kärber method serve as reliable estimates of prion titers from infected slice cultures, indicating 
that after 35 dpi prion titers are comparable to terminally infected brains(Wilham, et al., 2010). 
Detection of prions by traditional methods depends on various factors such as PK 
concentration, incubation time, and choice of antibody that could create discrepancies in the 
results obtained between samples. Since RT-QuIC seeding activity is not solely based on 
protease resistance(Vascellari et al., 2012), the OSCAR model could likely be adapted to other 
seeding prion species. However, it remains to be tested whether this model can be used 
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successfully for other strains and species. As the detection strategies continue to improve for a 
broad range of prions and strains(Orru et al., 2015a; Orru et al., 2015b; Orrú et al., 2015; 
Vascellari, et al., 2012), we believe that our OSCAR model could be useful in developing 
procedures that disrupt prion propagation. Distinct kinetic traces from an OSCAR assay could 
help us to understand more characteristics of prion strains.  Finally, using recombinant bank 
vole (Myodes glareolus) PrP as a substrate, a variety of prion strains could be rapidly amplified 
in an RT-QuIC assay to better understand mechanisms and alternative therapeutic 
approaches(Orrú, et al., 2015). 
This OSCAR model offers a high-throughput platform for extending the utility of integrated 
prion models to support rapid drug discovery efforts and antemortem diagnostics. As proof-
of-principle, we used the OSCAR system to test a small panel of anti-prion compounds that 
were characterized in animal models of prion diseases(Caughey et al., 1994; Demaimay et al., 
2000; Karapetyan, et al., 2013). First, we used the OSCAR model to test Congo red for its 
potent curing effects in prion-infected cells(Caughey, et al., 1994). The mechanism of action 
of this polyanion is its high-binding affinity to amyloids that hyperstabilizes the 
aggregates,(Caspi et al., 1998) thus interfering with the formation of toxic oligomers. Although 
Congo red is neuroprotective in prion-infected cerebellar slices(Falsig et al., 2012), a 
paradoxical increase in PK-resistant prions as shown with stronger immunoblotted band 
intensity, has also been reported(Aguzzi, et al., 2012). Interestingly, using the OSCAR model, 
we found it reduced the seeding activity in RML scrapie-infected slice cultures (Fig. 5A-E), 
thereby supporting a neuroprotective role. Next, we evaluated the small molecule quinacrine. 
Previous reports suggest treatment with quinacrine results in a strong anti-prion effect in cell 
culture and it is routinely used in screening libraries(Doh-Ura et al., 2000; Nguyen et al., 2011). 
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However, efforts to translate this compound in human trials failed(Geschwind et al., 2013). As 
further studies determined that quinacrine exhibits poor CNS bioavailability, attempts were 
made to increase its bioavailability using mice deficient in the P-glycoprotein multi-drug 
resistance (MDR) transporter. However, this study showed only a transient reduction in both 
PrPSc and its conformational stability while encouraging drug resistance(Ghaemmaghami et 
al., 2009). In slice cultures, chronic treatment with quinacrine showed an intermediate decrease 
in seeding activity when compared to control slices infected with RML scrapie (Fig. 5A-E). 
This anti-prion effect in cultured slices could be attributed to direct interaction of the drug with 
the brain slices and early initiation of the treatment regimen. Lastly, we tested astemizole, as 
it was reported to show anti-prion activity in cell culture models and to marginally extend the 
survival of prion-infected mice (~4%) despite having no effect on reducing PrPC levels or PrP 
mRNA levels in PK1 cells(Karapetyan, et al., 2013). Astemizole crosses the blood-brain 
barrier and reduced the PK-resistant PrP in the persistently infected cell culture model. 
Although its exact anti-prion mechanism of action is not known, it has been shown to stimulate 
autophagy. Conversely, in our study, astemizole did not show any reduction in seeding activity 
and the seeding kinetics remained similar to that of cerebellar slice cultures infected with RML 
scrapie (Fig. 5A-E). This difference may be attributed to a highly sensitive readout using RT-
QuIC assay to detect seeding prions. These initial studies demonstrate the translational 
potential for the OSCAR model to further test novel compounds and may have utility in future 
treatment paradigms involving a wide range of prion strains.  
Emerging evidence suggests that protein misfolding plays a key role in major 
neurodegenerative disorders that have prion-like templated conversion of proteins, including 
Parkinson's, Alzheimer's, frontotemporal dementias, multiple sclerosis, multiple system 
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atrophy and Huntington’s diseases. No drugs are available for halting or reversing prion 
diseases or any other prion-like neurodegenerative disorders(Berry et al., 2013). Additionally, 
drugs demonstrating excellent effects in cell culture and in vivo models of scrapie 
paradoxically fails to show any effect on CJD prions(Giles, et al., 2015) or in clinical 
trials(Geschwind, et al., 2013). Also, mouse cell lines persistently infected with prions were 
developed to establish in vitro models of scrapie(Butler et al., 1988; Caughey et al., 1989) for 
drug testing but compounds identified through a high-throughput drug screening(Klohn et al., 
2003) had little or no effect against CJD prions. Furthermore, no cell culture model can 
propagate the CJD prions in culture. We speculate that the OSCAR model could be extended 
to CJD human prions, thereby filling a critical void because currently available models are 
medically intractable against CJD prions. 
In summary, we have established a highly sensitive integrated technique for the efficient 
detection of seeding prions (Fig. 7). Our OSCAR model using an organotypic slice culture 
assay coupled to the RT-QuIC assay may be able to accelerate translational research by testing 
a large number of anti-prion compounds, including small molecules, against prion infection. 
Furthermore, the OSCAR model could act as a prototype for other protein misfolding disorders 
(PMDs)that obey principles of aggregation and propagation. In addition, using OSCAR with 
transgenic mouse models and genetic manipulation may provide mechanistic insights into the 
cell-to-cell transmission of prion-like aggregates and the progression of neurodegenerative 
diseases. 
Materials and Methods 
Reagents: Dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), 45% glucose, 
kynurenic acid, proteinase K (PK), sodium chloride (NaCl), Tris-HCl and Triton X-100 were 
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purchased from Sigma (St. Louis, MO). Millicell 6-well plate inserts (Biopore filter CM, PTFE 
inserts 30-mm diameter and 0.4-um pore size, Cat No. PICM03050), E. coli Rosetta DE3 
competent cells, Overnight ExpressTM Autoinduction System 1 (Cat. no. 71300-3) and 
BugBuster® Master Mix (Cat No.  71456-4) were purchased from Millipore (Billerica, MA). 
Bradford protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA). Horse 
serum, penicillin, streptomycin, and low-melting agarose (Cat No. 15517-022) were purchased 
from Invitrogen (Carlsbad, CA). Anti-PrP mouse monoclonal antibodies POM1 and 6D11 
were purchased from Prionatis AG (Schlieren, Switzerland) and Covance, respectively. Anti-
β-actin antibody was purchased from Sigma-Aldrich. Alexa Fluor 680 conjugated goat anti-
mouse IgG was purchased from Invitrogen. Goat anti-rabbit IR800 conjugated IgG was 
purchased from Rockland Immunochemicals (Gilbertsville, PA), propidium iodide (PI) from 
Molecular Probes (Cat No. P3566), and Halt™ Protease and Phosphatase Inhibitor Cocktail 
(Cat No. 78440) from Life Technologies. All other reagents were obtained from Thermo Fisher 
Scientific (Waltham, MA) unless otherwise mentioned. 
Slice cultures and infections: All the experiments involving animals followed protocols 
approved by Iowa State University’s Institutional Animal Care and Use Committee (IACUC) 
and by the IACUC at the National Animal Disease Center (protocol number: 3985). 
Organotypic cerebellar slices for prion assay were prepared as previously described(Falsig, et 
al., 2008a; Harischandra, et al., 2014). In brief, brain slices were prepared from 9- to 12-day-
old mouse pups from either wild-type (WT, C57BL/6) or transgenic prion-overexpressing or 
knockout mice (Tga20 or prnp -/-, respectively) using a microtome (Compresstome™ VF-300, 
Precisionary Instruments). After dissecting the cerebellum from the whole brain, the 
cerebellum was oriented in the sagittal plane in the Compresstome’s specimen tube, which had 
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been prefilled with 2% low-melting-point agarose. The agar was quickly solidified by clasping 
the specimen tube with a chilling block, and then the specimen tube was inserted into the 
slicing reservoir filled with freshly prepared, ice-cold Gey’s balanced salt solution 
supplemented with the excitotoxic antagonist, kynurenic acid (GBSSK). To prepare GBSS, we 
added the following in solution in the following order from 10x stocks to obtain the final 
concentrations per liter 8 g NaCl, 0.37 g KCl, 0.12 g Na2HPO4, 0.22 g CaCl2•2H2O, 0.09 g 
KH2PO4, 0.07 g MgSO4•7H2O, 0.210 g MgCl2•6H2O, 0.227 g NaHCO3. The compression lip 
located in the cutting chamber helps stabilize the brain specimen while obtaining 350-µm thick 
slices with the blade set at a medium vibration speed. Slices were collected at the specimen 
tube’s outlet and transferred to another plate with fresh prefilled GBSSK. Slices were exposed 
on ice for 1 h to either normal brain homogenate (NBH) or Rocky Mountain Labs scrapie brain 
homogenate (RML scrapie) with 100 µg/ml of brain homogenate total mass diluted in 1 mL 
GBSSK. Later, the slices were washed twice in 6 ml ice-cold GBSSK, transferred to Millicell 
6-well plate inserts (7-9 slices per insert) and were incubated in a humidified atmosphere of 
5% CO2 at 37
oC. Culture media was exchanged every other day with fresh media until the 
infected slices reached their pre-determined endpoints. For scaling up the experiments, we 
cultured a pool of ~50 slices per 6-well plate, all from a single litter with the same genotype, 
and exposed to either NBH or RML scrapie brain homogenates. These slices were triple-
washed in ice-cold GBSSK before plating and maintained as described above. Slice cultures 
were harvested at various endpoints by washing twice in 2 ml of ice-cold PBS. Lysates were 
prepared in 1X PBS by three freeze-thaw cycles and subjected to five 30-sec sonication pulses 
each in a cup sonicator. When testing anti-prion compounds, the compounds were added from 
stock solutions (1000X) to slices at 15 days post-inoculation (dpi), and then fresh media with 
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compounds were exchanged every other day and harvested at 31 dpi as described above. 
Viability assays: Viability assays in organotypic cerebellar slices were performed as 
previously described with modifications(Herrmann et al., 2015a). Dead cells were selectively 
stained by incubating the slices in culture media with 5 µg/ml of PI, which is a nontoxic dye 
that selectively binds to nuclei of dead cells and can be used to image live slice cultures.  After 
30 min, the PI media was replaced with fresh culture media before imaging at 2X and 10X 
magnification through a Nikon TE2000-U microscope (Tokyo, Japan) coupled to a SPOT 
digital camera (Diagnostic Instruments, Sterling Heights, MI). All the images were processed 
using ImageJ with constant threshold settings.  
Immunoblotting: Western blot analyses and limited proteolysis were performed as described 
previously(Aguzzi, et al., 2012; Anantharam et al., 2004; Choi, et al., 2010; Harischandra, et 
al., 2014) with minor modifications. Briefly, slices were washed twice in ice-cold PBS and 
harvested with PBS, unless otherwise specified. After protein assay, equal homogenates were 
separated on 15% SDS-PAGE gels. After electrophoresis, proteins were transferred to a 
nitrocellulose membrane. The membranes were blocked using LI-COR blocking buffer (LBB) 
for 1 h and probed overnight with the primary antibody followed by secondary antibody 
treatments using Alexa Fluor-conjugated anti-mouse or anti-rabbit antibodies. An Odyssey IR 
Imaging (LI-COR) system was used to capture and analyze images using Odyssey 2.0 
software, and densitometry was done using ImageJ. For Limited proteolysis, we used partial 
Proteinase-K digestion methods as previously described with a few modifications(Falsig, et 
al., 2008b; Harischandra, et al., 2014; Martin, et al., 2011). At 35 dpi, RML scrapie- and NBH-
inoculated slice cultures were homogenized in lysis buffer (1% Triton-X in PBS). After 
determining the protein concentration by Bradford assay, 200 µg of protein was digested with 
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25 μg/ml of Proteinase-K and incubated for 30 min at 37oC. When brain homogenates were 
used, 100 µg of protein was digested with 25 μg/ml of Proteinase-K for 45 min at 37oC. The 
digestion reactions were stopped by boiling the samples for 10 min. Samples were stored at -
80oC until Western blots analyses were performed as described above. Membranes were 
incubated with the POM1 PrP antibody (1:5000, Prionatis AG) overnight at 4oC and then triple-
washed with 0.1% Tween in 1X PBS. Secondary antibody incubations and washings were done 
as described above and fluorescence was captured using the Odyssey IR Imaging system.   
Dot Blot: Immunoreactivity of PrP from the prion-infected slice cultures was determined by 
dot-blot using Bio-Dot® Microfiltration System using manufacturer’s protocol as described 
previously(Sun et al., 2005). In brief, the slice cultures were harvested at pre-determined 
endpoints, and homogenates were prepared and protein concentrations were determined as 
described above. Next, 0.5 μg and 5 μg of homogenates were mixed with 200 μl of tris-buffered 
saline (1X TBS) with 0.1% Tween-20 and allowed to adsorb onto a nitrocellulose membrane 
for 1 h. The membrane was washed twice with 200 μl of 1X TBS using a gentle vacuum, 
blocked with 1X LBB for 30 min, incubated with mouse monoclonal POM1 anti-PrP antibody 
(dilution 1:5000) for 1 h at RT, and triple-washed with 1X TBS. Membranes were then 
incubated with Alexa Fluor 680-conjugated anti-mouse secondary antibody in LBB (1: 10,000) 
for 30 min followed by 3 washes in 1X TBS. As the loading control, membranes were probed 
with β-actin. Antibody-bound proteins were detected with the Odyssey IR Imaging system and 
densitometry was performed with ImageJ.  
Immunohistochemistry: After fixing the slices, antibody treatments were performed as 
described previously(Aguzzi, et al., 2012; Harischandra, et al., 2014; Sonati et al., 2013) with 
minor changes. Slices were rinsed twice with 1 ml of 1X PBS and fixed in 4% 
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paraformaldehyde (PFA) overnight at 4oC. Before antibody treatments, slices were washed 
twice with PBS for 15 min each at RT to remove residual PFA and incubated with blocking 
buffer (0.05% TritonX-100 and 3% goat serum in 1X PBS) for 1 h at RT. Primary antibodies 
were diluted (1:1000 unless otherwise stated) in blocking buffer and incubated for 2-3 days at 
4oC. The following antibodies were used: anti-NeuN (clone A60, Alexa Fluor®488 conjugated 
(Millipore, Cat No. MAB377X) and anti-PKCδ (Santa Cruz). After incubation with primary 
antibody, membranes were washed 4 times with PBS for 15 min each and incubated 1 h in the 
dark with the following secondary antibodies diluted 1:1500 in blocking buffer: Alexa Fluor 
555-conjugated anti-mouse secondary antibody or Alexa Fluor 488-conjugated anti-rabbit 
secondary antibody. The cell-permeable dye Hoechst 44432 (1:5000 for 3 min in PBS) was 
used to stain all nuclei. The culture membranes were removed from the inserts and mounted 
directly on microscope slides, with membranes facing the slide, using Fluoromount mounting 
medium (Sigma) and imaged with a SPOT color digital camera attached to a Nikon TE2000-
U microscope. 
Recombinant prion protein expression and purification: Recombinant prion protein (rPrP) 
was expressed and purified using previously reported protocols(Atarashi et al., 2008; Orru et 
al., 2011; Vascellari, et al., 2012; West Greenlee et al.; Wilham, et al., 2010). Briefly, N-
histidine-tagged prion protein-encoding plasmids of Syrian golden hamster residues for full 
length (23-231) or truncated (90-231) in pET vector (EMD biosciences) were transformed into 
E. coli RosettaTM2 (DE3) cells and grown under kanamycin and chloramphenicol as selection 
media. Protein expression was induced using Overnight Express™ Autoinduction System 1 
(EMD Millipore Cat No. 71300) with log phase mini-cultures as a starter culture. The bacteria 
were pelleted and lysed with BugBuster® Master Mix to isolate inclusion bodies. Inclusion 
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bodies were dissolved in 8 M of the denaturing agent guanidine hydrochloride (GuHCl) for 1 
h and mixed to pre-equilibrated nickel-nitrilotriacetic acid (Ni-NTA Superflow) resin (Qiagen 
Cat No. 30430) for 50 min on a rotating mixer. The beads were packed in an Akta #XK26 
column and purified using Ni-NTA-immobilized metal affinity chromatography (IMAC) on a 
Bio-Rad DuoFlow system operating at 4oC. On-column refolding was performed using 
gradient reduction of GuHCl. Pure rPrP was eluted from the IMAC using competitive 
imidazole binding with a linear gradient. Chilled dialysis buffer was added to the peak eluted 
fractions, filtered and dialyzed against three changes of chilled dialysis buffer (10 mM NaPO4, 
pH 5.8). Following dialysis, the rPrP was filtered, aliquoted and stored at -80oC. Protein 
concentration was determined by absorbance at 280 nm over the extinction coefficient before 
freezing as well as after thawing and filtering through 100-kD cutoff filters. Protein 
concentration was typically in the range of 0.5-0.7 mg/ml after dialysis. Each batch was 
routinely tested for quality and activity using Western blot and RT-QuIC assay respectively 
before using on test samples.   
RT-QuIC assay: RT-QuIC assay was performed using standard protocols from published 
reports(Haley et al., 2015; Orru, et al., 2015b; Wilham, et al., 2010) with slight modifications. 
Unless otherwise specified, the reaction mixtures consisted of final concentrations of 350 mM 
NaCl, 0.1 mM EDTA, 10 µM ThT, 0.1 mg/ml rPrP and 0.0025% SDS in 1X PBS. First, 5 μL 
samples from either brain homogenates or slice culture homogenates were diluted in a total 
reaction mixture of 100 μL. Plates subjected to RT-QuIC assay were sealed with Nalgene Nunc 
plate sealer. Plates were incubated at 42oC in either a CLARIOstar (BMG) or Cytation3 
(BioTek) plate reader with alternating 1-min shake (double orbital) and rest cycles. All samples 
were run at least in triplicates, and samples were judged to be positive as reported previously 
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when samples were run in quadruplicates(Orru, et al., 2015b; West Greenlee, et al.). Whenever 
triplicates were run, we averaged their fluorescence readings, and additionally we selected 
10xSD (standard deviation of negative controls) as the criteria for determining the threshold. 
Bottom plate recordings of ThT fluorescence (450±15 nm excitation and 480±10 nm emission) 
were taken every 30 min and data analysis was performed as reported previously(Orru, et al., 
2014) using MARS version 5.2.R8 or Gen 5 version 2.07.17 software when CLARIOstar 
(BMG) or Cytation3 (BioTek) were used, respectively, and the data were exported to Microsoft 
Excel for graphing. 
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Figure 1. Prion infected organotypic slice cultures exhibit distinct biochemical and 
neurodegenerative changes. (A) Lysates from organotypic cerebellar slices exposed to NBH 
or RML scrapie and cultured for 35 days were subjected to PK treatment and then Western 
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blotted (undigested samples were loaded after diluting 10 fold to prevent over-exposure on 
blots). RML-treated slices accumulate the PK-resistant PrP signal, but NBH-treated slices did 
not. (B) An equal amount of brain homogenates from WT mice was infected with RML scrapie 
either undigested or digested with proteinase K (PK) to detect PK resistance (designated as 
PrPSc) on immunoblot. Membranes were probed with anti-PrP (α-helix 1) mouse monoclonal 
antibody, POM1. The banding profile showed differential migration with banding profiles 
consistent with PrPC for undigested and PrPSc for digested samples. (C-D) Propidium Iodide 
(PI) incorporation to visualize dead cells in 49-dpi slice cultures. Quantification of PI+ cells 
from NBH or RML scrapie-infected slices using ImageJ. RML scrapie-infected cerebellar 
slices showed significantly higher cell death when compared to NBH-treated brain slice 
cultures. Data were analyzed using a two-tailed t-test; n = 6 biological replicates. Data are 
mean ± SEM (*p<0.05, **p<0.01, ***P<0.001). (E-F) Slices were stained with NeuN to 
determine any neuronal loss at 42 dpi. RML scrapie-infected slice cultures suffered significant 
neuronal loss as evidenced by NeuN+ area of percent NBH-treated slices. (G) RML scrapie-
infected slice cultures show pro-apoptotic signaling as evidenced by both upregulation and 
proteolytic activation of PKC and augmented cleaved caspase 3 when compared to controls. 





Figure 2. Sensitive and specific prion seeding activity from organotypic slice cultures on 
RT-QuIC assay. (A) Slice cultures from WT mice (C57BL/6 background) efficiently seed the 
RT-QuIC assay. Representative RT-QuIC responses shown for the reactions seeded with 5 ng 
of WT homogenates from either NBH or RML scrapie-infected slice cultures (21 dpi) or brain 
homogenates from mock or terminally-infected scrapie mice. Uninfected samples did not show 
seeding activity and stayed at the baseline throughout the reaction. (B) RT-QuIC traces for a 
log dilution series from Tga20 slice cultures (21 dpi) showing clear concentration-dependent 
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seeding activity. (Positive control = mock or clinical scrapie mice. Neg Con = mock / normal 
brain homogenate-infected samples). (C) Cultured slices from PrP-/- did not show seeding 
activity (both NBH and RML scrapie groups) at any seed concentration. Data from the traces 
shown are average of three replicates for each dilution. (D) Quantification of average ThT 
fluorescence values obtained over 60-hour period for each seed concentration tested from 
Tga20 slice cultures (21 dpi) shows a seed concentration-dependent increase. (E) 
Quantification of average amyloid formation rate (AFR) for each seed concentration tested 




Figure 3. Temporal seeding activity from prion-infected organotypic slice cultures: RT-
QuIC end-point dilution analysis in slice cultures from wild-type mice. (A) Organotypic 
cerebellar slices from WT mice infected with scrapie show time-dependent seeding activity. 
After RT-QuIC reactions were seeded with 5 ng of homogenate, seeding activity occurred only 
in RML scrapie-infected slice cultures, not in NBH-exposed slice cultures. NBH-treated slices 
and RML scrapie-infected slices at 1 dpi did not show seeding activity. The earliest detection 
of seeding activity was observed at 7 dpi with longer lag phases. Seeding strength showed a 
clear time-dependent increase as judged by time to reach threshold. Seeding activity was also 
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noted at 14 dpi, but the traces became stronger from slices at 21 dpi and continued to increase 
for later time points (28, 35 and 42 dpi). Data from each trace shown are the average ThT 
fluorescence of three replicate wells. (B-F) Seeded amplification of prions at log dilutions 
tested from cultured slices. Traces shown are average of 3 replicates from 42 dpi (B), 35 dpi 
(C), 21 dpi (D), 14 dpi (E) and 7 dpi (F). 
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Figure 4. Rapid kinetics and quantitative assessment of prions from slice cultures using 
RT-QuIC assay. (A) The average SD50/g of protein (Spearman-Kärber estimates) of slice 
cultures was calculated based on endpoint dilutions from (n=6 technical replicates) and plotted 
at time points (1, 7, 14, 21, 35 and 42 DPI) for both WT (n=3 biological replicates) and Tga20 
74 
(n=1 biological replicate) slice cultures. (B) The amyloid formation rate (AFR) was estimated 
by using the inverse of time in hours at which a trace crosses threshold fluorescence. The linear 
response AFR for cultured slices was both time- and seed concentration-dependent. (C) Dot-
blot showing immunoreactivity against POM1 antibody. Progressive increase in 
immunoreactivity for PrP with respect to time spent in culture, starting at 14 dpi. 
Immunoreactivity against β-actin was used as a loading control for normalization. (D) 




Figure 5. OSCAR model to determine the anti-prion activity of compounds. (A-C) 
Compounds known to have anti-prion activity against RML scrapie prions were tested. RT-
QuIC responses shown for 3 different seed concentrations (5 ng, 0.5 ng, and 50 pg) with or 
without compounds. Each trace shown is an average of 4 replicates (n=2 biological replicates). 
(D-E) Quantification of anti-prion activity of compounds with respect to percent ThT-positive 
wells at different seed dilutions. Amyloid formation rate (AFR) represents the anti-prion 
activity of compounds tested. 
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Figure 6. Prions generated in slice cultures are biologically active and OSCAR model can 
be adapted to whole brain slice cultures. (A) Efficient transmission of prions in slice cultures 
from serial passages shows comparable seeding activity between P1 and P2 slices. Traces are 
average of 3 technical replicates for each dilution. Additional dilutions were tested but only 
two seed concentrations (0.5 ng and 50 pg) shown here for brevity. Cerebellar slice cultures 
were prepared from Tga20 mice. Abbreviations: p1 = passage 1, WT slices treated with brain 
homogenate; p2 = passage 2, infected slice cultures harvested at 35 dpi, homogenized and used 
to treat fresh WT slice cultures) (B) corticostriatal slice cultures were prepared from 11-day-
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old Tga20 pups in similar fashion as cerebellar slice cultures and maintained for 42 dpi before 
testing on RT-QuIC assay. The seeding activity from RT-QuIC traces demonstrates the 
competence of seeding activity is highly dynamic and similar to seeds obtained from 




Figure 7. Schematic illustration of OSCAR workflow.  
The brain slice cultures were prepared in organotypic fashion obtained from neonatal mice and 
embedded in compressing lip and sliced. The slices were incubated with either normal or prion-
infected brain homogenates for 1 h, then washed and cultured with liquid air interphase on 
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membrane inserts. Treatments with compounds of interest began at 14 dpi in this study and 
slices were harvested at 31 dpi. Slices were homogenized and dilutions were used to seed RT-
QuIC reactions. RT-QuIC assay was performed in 96-well plate using recombinant prion 
protein as a substrate with continuous shake/rest cycles. The seeding activity was monitored 
in real time based on seeding using a thioflavin T (ThT) fluorescence readout and quantified. 
Positive wells can be clearly visualized based on the traces that cross the threshold fluorescence 
and by the rapid increase in intensity. The well-area scan image shows the intense amyloid 




Supplementary Fig 1. Organotypic slices are viable for a long period of time in culture. 
Slices cultured for 63 days were assessed for viability using Propidium iodide (PI) 
fluorescence. Percentage of relative PI uptake intensity was used to compare cell death. 
Staurosporine evokes significantly stronger cell death as compared with the slices cultured post 










Supplementary Fig 2. Slice cultures illustrate the time-dependent increase in average 
fluorescence readings. Correlation between days post infection (DPI) versus an increase in 













Supplementary Fig 3. Determining prion seeding activity from end point dilutions of 
infected scrapie brain homogenates. Serial dilutions of RML scrapie brain homogenates 
were used to seed RT-QuIC reactions; average of triplicate traces are shown. The 50% seeding 
dose (SD50) was calculated based on the number of wells turned positive for each dilution, 
while the SD50 was calculated as described in methods. In this case, approximate SD50 for the 




Supplementary Fig 4. Prion seeding kinetics between biological replicates have high 
reproducibility. RT-QuIC reactions seeded with the slice cultures from two separate 
experiments show similar seeding kinetics across the wide range of dilutions tested. 
 
 
Supplementary Fig 5. Original western blots for the cropped images used in Fig 1G. 
Regions of Western Blots shown in the figures 1G were highlighted in black boxes.  
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Abstract 
Modeling diseases using the ex-vivo platform accelerates the study of prions and other protein 
misfolding diseases (PMDs) that have long incubation times. One manifestation of prion 
disease is chronic wasting disease (CWD) that has a 2–3 year incubation period in cervids. 
CWD has been shown to have rapid transmission yet it remains difficult to diagnose, or control 
and impossible to treat. We have recently developed an integrated organotypic slice culture 
assay for the detection of scrapie prions using ultrasensitive prion seeding. However, there are 
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no such ex-vivo models to study CWD prions due to the strong transmission barrier from deer 
to wildtype mice. Therefore, we utilized a cervidized transgenic (Tg12) mouse model to 
develop and characterize the ex-vivo brain slice culture model for CWD. We tested for CWD 
infectivity in the cultured slices using sensitive seeding assays such as the real-time quaking-
induced conversion (RT-QuIC) assay and protein misfolding cyclic amplification (PMCA), 
along with the conventional methods of western blots and immunohistochemistry. Slice 
cultures from the Tg12 (elk sequence) PrP+/- genotype tested positive, but the slices from the 
PrP-/- genotype did not. We also tested the efficiency to propagate in-vivo of CWD prions 
generated in slices. The CWD prions generated in slices were transmitted efficiently back into 
the Tg12 mice and subsequently passed again with a reduction of incubation periods. Further, 
we established the activity of anti-prion compounds and the diagnostic utility of this CWD 
slice culture model. Our results demonstrate this integrated brain slice model of CWD provides 
a means to study prion propagation, CWD diagnosis to test potential therapeutics as they 
become available.  
 
Introduction 
Chronic Wasting Disease (CWD) is a transmissible spongiform encephalopathy (TSE) or prion 
disease of cervids, with a natural incubation period in the range of 2–3 years.(Williams et al., 
1980, 1993) The first detection of CWD was in a captive mule deer in the Colorado foothills 
in 1967. Currently, CWD has been reported in 24 states in the United States of America, in 2 
provinces in Canada, and in South Korea and Norway.(Hannaoui et al., 2017; Ricci et al., 
2018) CWD is a naturally occurring disease in both captive and wild cervids; it spreads rapidly 
through horizontal(Moore et al., 2016) or vertical transmission(Nalls et al., 2013). CWD prions 
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have been detected in a variety of tissue samples and biological fluids such as cerebrospinal 
fluid (CSF) and urine. CWD has been reported as transmissible to a wide host range by 
experimental inoculation.(Saunders et al., 2012) For example, CWD is transmitted to cattle by 
intracerebral (IC) inoculation.(Hamir et al., 2001) While there is no absolute species barrier 
demonstrated between CWD-infected deer and humans, it has been experimentally transmitted 
to several other species such as ferrets,(Sigurdson et al., 2008) raccoons,(Hamir et al., 2003) 
small ruminants,(Hamir et al., 2006) domestic cats,(Mathiason et al., 2013; Seelig et al., 2015) 
pigs,(Moore et al., 2017a) and non-human primates (squirrel monkeys were highly susceptible 
while Cynomolgus macaques were resistant).(Race et al., 2014) Conversely, human PrP-
expressing mice appear to be resilient to CWD infection despite not conclusively 
demonstrated.(Wilson et al., 2012) 
Despite CWD transmission to other species, wild-type (WT) mice have not been shown to 
support CWD prion infectivity. Therefore, transgenic mice expressing the deer PRNP sequence 
were developed to support the CWD prion in-vivo experimentation. These mice typically 
develop signs of CWD within 230 days following IC inoculation but will show signs in 160 
days if they are homozygous for PrP transgene.(Browning et al., 2004) Similarly, Kong and 
colleagues developed another line of transgenic mice that expresses elk PRNP sequence in a 
prion knockout background and has an incubation period of 118–142 days.(Kong et al., 2005) 
Another strain of mice termed as VM mice are susceptible to both Bovine Spongiform 
Encephalopathy and Scrapie are also tested for CWD prion infection. The first passage mice 
showed low attack rate (~5%) while the second passage mice showed 100% attack rates.(Lee 
et al., 2013) 
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The incubation period of CWD in experimental inoculations can exceed up to 3 years in 
cervids. Studying CWD prions in the laboratory can be time-consuming and requires adequate 
space equipped for cervid suites with high maintenance costs. Therefore, the purpose of this 
study is to develop and characterize an ex-vivo model of CWD to address some of the 
challenges in studying CWD prions. We have recently demonstrated that the integrated 
organotypic slice cultures and RT-QuIC (OSCAR) model using RML scrapie prions is a 
realistic model to study prion biology in a reduced time. This model utilizes advantages of both 
ex-vivo experimentation and ultrasensitive prion detection. Brain slices maintain a 3D 
environment with the integration of different cell types in the brain such as: neurons, 
astrocytes, microglia, and oligodendrocytes. Therefore, we hypothesized that a slice culture 
model for CWD prions would facilitate the study of the biology of these prions in a reasonable 
and shorter timescale. In this study, we developed and characterized the brain slice cultures to 
examine the CWD prions in culture. The slice cultures support CWD prion replication, and the 
kinetics of the prion seeding was quantified at different time points. Furthermore, we 
demonstrated that these CWD brain slice culture models could be used to test pharmacological 
compounds and the diagnostic utility of these slice cultures.  
 
Materials and Methods  
Ethics Statement 
The experiments were performed according to Guide for the Care and Use of Laboratory 
Animals. All experiments involving animals were done with the approval of Institutional 
Animal Care and Use Committee (IACUC) at Iowa State University and the National Animal 
Disease Center under protocol number 3985.   
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Slice Culture Assays 
Organotypic cerebellar slice cultures were done as reported previously.(Kondru, et al., 2017a) 
In brief, organotypic cerebellar slices were prepared from 10- to 12- day-old mouse pups from 
either transgenic (Tg12) or prion protein knockout (prnp-/-) mice. For the cerebellar slices, the 
cerebellum was dissected out from the whole brain and positioned in the sagittal plane of the 
specimen tube in a microtome. The cerebellum was held in the specimen tube using 2% low-
melting agarose. After positioning the cerebellum, the tube was chilled with an ice-cold 
chilling block to quickly solidify the agarose. The tube was then inserted into a tank filled with 
ice-cold Gey’s Balanced Salt Solution along with kynurenic acid (GBSSK). Slices of 350 µm 
thickness were prepared using a medium speed setting on the microtome. After collection, 
slices were transferred to a plate filled with cold GBSSK. Later, brain homogenates from either 
uninfected deer or CWD infected deer obex were used to infect a pool of 20–30 slices. The 
slices were incubated for 1 hr at 4°C with brain homogenates diluted in the GBSSK solution 
to a final concentration of 100 µg/ml (W/V). After treatment, slices were washed twice with 
fresh, ice-cold GBSSK and then transferred onto membrane inserts preloaded in a 6-well plate. 
The residual buffer was removed, and 1 ml of fresh media was added to the basolateral 
compartment of the plate, avoiding any air bubbles at the base of the membrane. The slices 
were maintained in a standard cell culture incubator with 5% CO2 at 37°C. The slice culture 
media was replaced on alternate days with pre-warmed media. After the desired length of time, 
the slices were harvested with ice-cold phosphate buffered saline (PBS) and pelleted. The 
pellets were stored at -80°C until analysis. For immunohistochemistry (IHC), the slices were 
washed once in ice-cold PBS, and 4% paraformaldehyde was added for overnight treatment at 
4°C. For testing the activity of anti-prion drugs on the slices, 1000X stock concentrations of 
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drugs were used for treatments. The treatments were started at day 15 and followed up by the 
addition of fresh media with compounds on every alternate day up to 35 days. For testing 
rectoanal mucosa-associated lymphoid tissue (RAMALT) samples, the RAMALT homogenate 
was filtered through a 0.22 µ filter, and 100 µg/ml of the homogenate was exposed to 7-day 
old slices for 24 hours in the media, followed by replacement with fresh media and cultures 
for an additional 28 days in regular media. 
Animal Inoculations  
The slice culture lysates were injected into 6–8-week-old Tg12 mice that express the elk prion 
protein sequence. The lysates were prepared from a pool of 6–7 slices washed with ice-cold 
PBS twice, pelleted and frozen in -80oC until injection. The pellets were homogenized in 60 
µl of PBS with a fine needle and inoculated to the brain slice culture homogenate at 30 
µl/mouse via intracranial injection into the right cerebral hemisphere at the level of the 
temporal bone. Samples were collected after animals exhibiting clinical signs had died. For 
immunohistochemistry evaluation, various regions of the brain were fixed in formalin, later 
changed to 10% neutral buffered formalin, and then embedded in paraffin wax. Sections of 4 
µm thickness were affixed to slides for immunolabelling with antibodies. Anti-PrP 6H4 
antibody was used to visualize the PrPCWD in the sections. 
Western Blot Analysis  
Proteinase K digestion and western blot analysis were done according to previously published 
protocols.(Anantharam, et al., 2008; Kondru, et al., 2017a; Nichols et al., 2012; Orru et 
al., 2015c) In brief, after washing the slices with ice-cold PBS twice, they were harvested using 
PBS. Equal amounts of protein were loaded on 15% sodium dodecyl sulfate polyacrylamide 
gel electrophoresis SDS-PAGE gels after determining the concentrations using a Bradford 
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assay. Proteins were separated using electrophoresis and later transferred onto a nitrocellulose 
membrane. These membranes were blocked with LI-COR blocking buffer (LBB) for an hour. 
They were then incubated with the primary antibodies overnight, followed by a secondary 
antibody incubation using an Alexa Fluor-conjugated anti-mouse antibody. LI-COR’s Odyssey 
IR imaging system was used to capture the images. For Proteinase K digestion experiments, 
25 µg/ml of Proteinase K was used to digest 200 µg of protein for 30 minutes at 37°C followed 
by boiling samples for 10 minutes. These samples were used to separate the proteins using 
electrophoresis after transferring the proteins onto nitrocellulose membranes conjugated with 
POM1 PrP antibody at 1:5,000 concentration (Prionatis, AG) overnight at 4°C. Secondary 
antibodies were added after washing with 0.1% Tween in 1X PBS three times. Images were 
captured with an Odyssey IR imaging system. 
Immunohistochemistry 
Paraffin-embedded tissues were analyzed using immunohistochemistry for the detection of 
PrPCWD. In brief, brain slices were deparaffinized and rehydrated prior to a 20-minute autoclave 
cycle in an antigen retrieval solution (Dako Target Retrieval Solution, Dako Corp., Carpinteria, 
CA). Tissues were then blocked with 3% hydrogen peroxide and Background Buster (Innovex 
Biosciences Inc., Richmond, CA) for 20 minutes each at room temperature. The primary 
antibody, Anti PrP mAb 6H4 (1:200; Prionics, Zurich, CH), at a concentration of 0.9 mg/ml, 
was diluted in Dako Antibody Diluent and incubated for 96 hours at 4°C. Mouse brain tissues 
were incubated for 15 minutes in 98% formic acid prior to a 30-minute autoclave cycle. Tissues 
were then incubated with primary antibody overnight at 4°C (6C2; CVI-WUR, Lelystad, NL). 
The secondary antibody, Dako EnVision+ Dual Link System HRP, was incubated at room 
temperature for 45 minutes. Tissues were then washed with Tris-buffered saline and .05% 
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Tween 20 (TBS-T). A DAB Peroxidase Substrate Kit (Vector Laboratories Inc., Burlingame, 
CA) was used to stain the slides for three minutes followed by a counterstain of hematoxylin 
and eosin (Leica Microsystems Inc., Wetzlar, DE) for two minutes. Tissues were then 
dehydrated, and coverslipped. Images for the figures were captured using a Nikon DS camera 
on a Nikon Eclipse 55i microscope. 
Recombinant Prion Protein Purification  
Truncated Syrian hamster recombinant prion protein (SHrPrP) amino acid residues 90–231 
was expressed and purified as per previously published protocols.(Kondru, et al., 2017a; 
Moore et al., 2017b; West Greenlee et al., 2016) In brief, SHrPrP (90–231) was expressed in 
the Rosetta™(DE3) strain of E.coli with kanamycin and chloramphenicol as the antibiotics of 
selection. Overnight autoinduction supplements were added to express the protein. Since 
SHrPrP is associated with inclusion bodies, BugBuster (Millipore) was used to lyse the 
bacterial cells and isolate inclusion bodies. These inclusion bodies were denatured in 8M 
guanidine hydrochloride (GuHCl) for about an hour and later preequilibrated with nickel-
nitrilotriacetic acid (Ni-NTA Superflow) resin for 50 minutes on a rotator. After equilibration 
with Ni-NTA beads, the bodies were loaded into the AKTA#XK26 column and purified using 
affinity chromatography on a Bio-Rad DuoFlow system at 4°C. On-column refolding was done 
from 100% denaturing to 100% refolding conditions. Elution of pure rPrP was due to the 
competitive binding between imidazole and rPrP to Ni-NTA resin. After elution, peak fractions 
of the pure rPrP were collected in a pre-chilled dialysis buffer (10mM Sodium phosphate 
buffer, pH 5.8) and dialyzed in two exchanges of 3.6 L of dialysis buffer. Finally, pure rPrP 
was filtered and the concentration of protein was determined using the absorbance at 280 nm. 
The absorbance at 280 nm was multiplied by the extinction coefficient to get the final rPrP 
92 
concentration in mg/ml. Protein was aliquoted and stored at -80°C until being used for 
experiments. Each batch of purified protein was tested for quality using a western blot analysis 
and test plates before being subjected to a seeding assay.  
Real-Time Quaking-Induced Conversion (RT-QuIC) Assay 
The RT-QuIC analysis was done as per previously published protocols.(Haley et al., 2016; 
Henderson, et al., 2015; Kondru, et al., 2017a; Orru, et al., 2015b) Briefly, assay was done in 
either Cytation 3 (BioTek) or CLARIOstar (BMG), and the reaction mixture consisted of 350 
mM NaCl, 0.1 M EDTA, 10 µM ThT, 0.1 mg/ml rPrP, along with 0.0025% SDS in PBS. 95 
µl of the reaction mixture was loaded in each well of a 96-well plate with 5 µl of seed coming 
from either CWD or normal brain homogenates (NBH) and either slices infected with CWD 
or NBH. The reaction was carried out in a Nunc 96-well plate with a sealer and the plates were 
incubated at 42°C in the plate reader with alternating 1-min. shake and rest cycles. ThT 
fluorescence readings were taken every 30 min. with a 450±15 nm excitation and 480±10 nm 
emission, and data analysis was performed using MARS V5.2 R8 and Gen 5 version 2.07.17 
software for CLARIOstar and Cytation 3 respectively. After exporting the fluorescence 
readings, graphs were plotted with GraphPad Prism 7.0 (GraphPad Software, Inc., La Jolla, 
CA). A sample was determined as positive when it crossed the fluorescence threshold, which 
is defined as the average mean fluorescence of control samples plus 10 standard deviations. 
Each sample was tested in triplicates or quadruplicates. 
Protein Misfolding Cyclic Amplification (PMCA) 
The slice culture samples were diluted and blinded. PMCA was performed as described 
previously.(Nichols et al., 2009) In brief, the brains from 4–6-week-old mice expressing the 
cervid PRNP sequence were harvested after perfusion and homogenized into a 10% w/v 
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solution by placing brain tissue in a tube with 2.5 mm glass beads (BioSpec), PBS with 
150 mM NaCl, and 4 mM EDTA (PMCA buffer). Then the solution was homogenized in a 
Blue Bullet homogenizer (Next Advance) for 4 min. Once homogenized, samples were 
clarified from debris by centrifugation. The supernatant was removed and stored at -80°C to 
be used as the substrate for PMCA reaction. A pool of 7 slices was homogenized in 100 µl of 
lysis buffer and was homogenized as described previously.(Kondru, et al., 2017a) The lysates 
were subjected to three 10-fold dilutions in PBS and used to seed the PMCA reactions. After 
PMCA, the amplified samples were visualized by western blot as described in the previous 
report.(Nichols et al., 2015) 
Dihydroethidium (DHE) Conversion Assay 
To determine the reactive oxygen species (ROS) generated by CWD prions, DHE conversion 
assay was performed as described previously.(Herrmann et al., 2015b) The adherent slices in 
the culture at 42 days post-inoculation (dpi) were washed twice in pre-warmed GBSS and 
incubated with 10 µg/ml DHE for 20 min in GBSS. Fluorescence microscopic imaging was 
performed on the slices using a 10X objective. The images were captured at 3–4 randomized 
areas per slice and quantified using ImageJ with similar threshold settings. 
Results 
Brain Slice Cultures from Cervidized Mice Support CWD Infectivity 
Organotypic cerebellar slice cultures prepared from 9- to 12-day-old transgenic cervidized 
(Tg12) and PrP-/- pups were infected with CWD or NBH and maintained in cultures up to 
52 dpi. The CWD prions that accumulated in these slices were detected using RT-QuIC 
assay based on their seeding ability. As hypothesized, the Tg12 slices treated with NBH as 
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well as PrP-/- slices treated with CWD or NBH did not show the infectivity (Fig. 1A). Prion 
seeding activity from cerebellar slices was also observed using serial PMCA (sPMCA). 
Infectious prions were amplified only in slices from Tg12 pups infected with CWD brain 
homogenate, and not in PrP-/- slices. This reflects similar observations made with the RT-
QuIC assay (Fig. 1B). From both RT-QuIC and sPMCA it is evident that only cervidized 
slices (and not slices derived from PrP-/-) were able to maintain the CWD prions and develop 
PK-resistant bands on the western blot. Next, the slice cultures were stained for deposition 
of resistant PrP as described in the methods for IHC. Distinct immunoreactivity of PrPCWD 
was observed in the slices infected with CWD but not in any controls (Fig. 1C). For the 
electrophoresis profile, the lysates of the slices were digested with Proteinase K. The slices 
infected with CWD brain homogenate have shown a distinct pattern of di-, mono-, and 
unglycosylated PK-resistant bands of PrPCWD on immunoblots, with bands, shifted lower 
than those from slices not treated with Proteinase K. This indicates a lower molecular mass 
of fragments after treating with Proteinase-K, along with the characteristic banding pattern 
of misfolded prions (Fig. 1D). Finally, we measured the ROS production from the slice 
cultures using the DHE conversion assay and the fluorescence was quantified. The 
cervidized slices infected with CWD demonstrated significantly higher ROS reactivity 
when compared to controls (Figure 1E). Taken together, these results suggest the CWD 
prions have the ability to infect and propagate in the slice cultures when cervidized PrP 
sequence transgene is introduced.  
Kinetics of CWD Prion Propagation in Ex-Vivo Cerebellar Slice Cultures 
Tg12 slices infected with CWD brain homogenate were cultured for various periods and 
harvested after 1, 21, 28, 35, 42, and 48 days post-infection (dpi). The slice cultures 
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demonstrated a low seeding ability at 21 dpi (Fig. 2A) and continued to increase at later time 
points. To further delineate the seeding dose (SD) required for the RT-QuIC assay, we tested 
serial 10-fold dilutions of 52 dpi slice culture homogenates from 50 ng to 50 fg; initial seeding 
activity was observed from the 50 ng dose up to 50 fg (Fig. 2B). To compare the seeding 
activity of prions in slice cultures with CWD brain homogenate, we tested different 10-fold 
dilutions of a CWD brain homogenate in the RT-QuIC assay. The seeding kinetics of the brain 
homogenates was compared to the cultured slices (Fig. 2C). A time-dependent increase in the 
accumulation of prions was observed from the SD50 (seeding activity, 50%) values and reached 
the maximum by 7 weeks post-infection in the slices, after which, the infectivity peaks 7 
weeks (Fig. 2D) and suggesting that the seeding kinetics are comparable to the CWD brain 
homogenate. 
Slice Cultures as Models for Transmission Assays and Screening Therapeutics 
The slice cultures were treated with three anti-prion compounds and assayed at various doses 
to determine the prion seeding activity (Fig. 3A). Congo red reduced the amplification kinetics 
of misfolded prions, which was evident at 5 ng and 0.5 ng seeding doses of CWD-infected 
slices. Likewise, at a seeding dose of 50 pg Congo red completely inhibited the seeding activity 
(Fig. 3A). To test the diagnostic ability of slices from clinical samples, the infectivity of recto-
anal mucosa-associated lymphoid tissue (RAMALT) samples were used. The 100 µg 
RAMALT sample was homogenized and exposed to the slices in culture media for 24 hours 
on day 7 and were cultured for 3 weeks. Subsequently, the slices were harvested, and lysates 
of different concentrations (50 ng to 50 pg) were used to compare the seeding ability of these 
slices with the CWD RAMALT sample as a positive control. Prion amplification kinetics 
suggested a concentration and PRNP expression dependent seeding activity. The slices 
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exposed to 50 ng of the CWD-infected RAMALT sample had the highest seeding ability, 
followed by other seeding doses of slices, when compared to the slices of the control RAMALT 
sample (Fig. 3B).  
Infectivity of Prions Generated in Slice Culture Models 
To test whether prions generated in slice cultures were biologically active, we intracerebrally 
inoculated Tg12 mice with CWD-infected slices (passage 1). The animals were euthanized 
when clinical signs became apparent and had a median survival time of 208 days. NBH treated 
brain slices were inoculated in a similar way, but had a prolonged lifespan reaching up to ~500 
days. Brain homogenate from a passage 1 mouse was subsequently passaged by intracerebral 
inoculation to other Tg12 mice (passage 2) and the mice were observed for clinical signs. The 
second passage had earlier clinical signs with a median survival of 139.5 days (Fig. 4A). The 
seeding activity of the passage 1 brain homogenates were tested in serial 10-fold dilutions 
using the RT-QuIC assay and the misfolded prions that accumulated were comparable to the 
CWD brain homogenate (Fig. 4B). Immunohistochemistry was used to detect PrPCWD in 
various brain regions of mice inoculated with the slice cultures. PrPCWD immunoreactivity was 
observed in all of the brain regions of animals inoculated with CWD-infected slices, but not 
in control animals (Fig. 4C). 
Discussion 
The nature of CWD prions in ex-vivo brain slice cultures has not been characterized. In the 
current study, we extended the brain slice culture model by coupling it with sensitive seeding 
assays like RT-QuIC and PMCA for detection of the CWD prions. CWD prions are reluctant 
to propagate in Wild-type (WT) mice or slice cultures from WT mice. Therefore, we prepared 
the slice cultures from a transgenic mouse model that express a cervidized sequence of PrP. 
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The slices were cultured for 35 days and tested for seeding activity using the RT-QuIC assay 
(Fig. 1A). The PrP-/- slices treated with CWD and slices treated with NBH did not show 
amplification in both assays, indicating that prions replicate in cerebellar slice cultures. Next, 
we characterized seeding ability using PMCA with a similar profile of prion amplification that 
is specific to the PrP expression and in agreement with the RT-QuIC results (Fig. 1B). Unlike 
the RML scrapie strain that reached maximum titers by 42 dpi in WT slices, CWD prions took 
~23% longer to reach maximum titers in slice cultures from Tg12 mice. One possible 
explanation for this long incubation period may be lower amplification kinetics of CWD prions 
in the heterozygous PrP genotype for Tg12 mice compared to RML scrapie. Brain samples 
from CWD-infected captive mule deer have PrPCWD deposition mostly in the medulla and basal 
ganglia with lowest accumulations in the cerebral cortex and mild cerebellar 
involvement.(Liberski et al., 2001) Therefore, utilizing the slice cultures from brain regions 
where CWD prion preferentially attack can be speculated as a good substitute. Additionally, 
the slice cultures were also tested for immunoreactivity of PrPCWD in the sections and PK-
resistant prions on western blot. We tested the accumulation of misfolded prions in slices at 
3 weeks and reached maximum titers by 7 weeks. Dihydroethidium (DHE) is a specific adduct 
of reactive oxygen species and forms a  product 2-hydroxyethidium that can be captured 
using fluorescence. CWD prions cause oxidative stress in the slices at 42 dpi and the slices 
with PrP+/- show significantly higher DHE reactivity when compared to all the controls. 
Characterizing the seeding activity at various time points reveals a steady increase in the prion 
titers, suggesting a time-dependent amplification of CWD prions in the slice cultures. A slice 
culture at 52 dpi was tested for seeding ability and is comparable to a terminally ill CWD brain 
homogenate. PrP misfolding was evaluated for each dilution based on seeding ability of log 
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dilutions at each time point. An example of 52 dpi slices is shown in Fig. 2B. To quantify the 
seeding activity of slice cultures, the Spearman-Kärber method was used to determine the SD50 
(seeding activity, 50%) values as described previously.(Henderson, et al., 2015; Kondru, et al., 
2017a) The seeding activity quantified at 21 dpi was lower and reached a maximum after 7 
weeks in culture (Fig. 2D). Overall, the quantification of slice culture prions had a time-
dependent increase in the accumulation. Anti-prion compounds have been shown to have 
distinct effects with respect to different strains. To determine the activity of anti-prion 
compounds on the CWD prions in the slice cultures, we tested different known anti-prion 
compounds: Astemizole, Congo red, and Quinacrine. While Astemizole did not show any 
reduction in the prion titers, Quinacrine promoted the seeding ability of CWD prions (Fig. 3A). 
This phenomenon is similar to previously reported studies in transgenic mice that demonstrated 
how quinacrine promotes the resistance of CWD prions through conformational changes.(Bian 
et al., 2014) However, congo red reduced the seeding activity of the CWD prions in the slice 
cultures. The slice cultures were also tested for transmission efficiency of the infectivity from 
the RAMALT rectal biopsies of deer.(Monello et al., 2013) These results suggest slice culture 
models would be suitable for picking up infectivity from the exposed biological material. The 
utility of this model may be valuable if it can be extended to experimental testing of the 
transmissible prions from a variety of biological fluids that are known to harbor infective 
prions. However, the experimental range of infectivity is yet to be discerned. Although it 
remains to be tested, this model may be explored to determine strain characteristics based on 
the genotype of cervid PrP sequence as new animal models emerge.(Duque Velasquez et al., 
2015) The broader dynamic range of seeding assays enables for a more sensitive and accurate 
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Fig. 1. In-vitro seeded amplification of CWD prions from organotypic slice cultures using 
RT-QuIC assay and PMCA (A) Slice cultures from Tg12 (PrP +/-) efficiently seed the RT-
QuIC assay. PrP -/- slices prepared in the blinded fashion with the genotypes blinded. 
Representative RT-QuIC traces were shown for the reactions seeded with 5 ng of slice culture 
homogenates from either CWD BH infected slice cultures (42 dpi) or brain homogenates from 
CWD-infected deer showed strong positive peaks. However, the slices treated with NBH or 
PrP -/- slices infected and cultured with CWD BH did not show seeding activity and stayed at 
the baseline throughout the reaction period. (n>15 independent batches of slice cultures). 
Cultured slices from PrP-/- did not show seeding activity (both NBH and RML scrapie groups) 
at any seed concentration. Quantification of average ThT fluorescence values obtained over 
60-hour period for each seed concentration tested from slice cultures shows the similar activity 
of the CWD BH seed. Each trace is a combined average of 3 technical replicates and 2 
biological replicates from a pool of 7-10 slices. (B) Immunohistochemistry of PrPCWD using 
6H4 antibody was performed.  Representative image of the cross-section of the slice was 
shown from a 42 dpi slices. (C)The PK-resistant prion show immunoreactivity from the slice 
cultures obtained from PrP +/- slice cultures but not from the PrP -/- slices infected and cultured 
at 42 dpi. Similarly, NBH slices do not show immunoreactivity for PK-resistant prions (image 
not is shown). Membranes were probed with anti-PrP mouse monoclonal antibody, POM1. 
Representative western blot was shown. (E) CWD prions induced oxidative stress was 
measured using DHE conversion assay and quantified using ImageJ. CWD BH infected 
cerebellar slices showed significantly higher ROS generation when compared to NBH treated 
brain slice cultures or PrP -/- slice cultures. Data were analyzed using one-way ANOVA; n = 





Fig. 2. Seeding profile of CWD prions from the organotypic slice cultures 
(A) Slices were infected with either normal deer brain homogenate (NBH) or CWD-infected 
deer brain homogenates and cultured up to 52 dpi. Representative traces from an average of 
triplicate reactions were shown for each time points tested (1, 21, 28, 35, 42 and 48 dpi). (B) 
The lysates were prepared from slices at 52 dpi and serially diluted 10-fold ranging from 50 
ng to 50 fg. Reactions consisted of 5ul of these dilutions as seed and tested in triplicate in the 
RT-QuIC assay. (C) A representative western blot demonstrating the PK-resistant prion, a 
biochemical hallmark accumulating in the organotypic cerebellar slices present only in CWD-





Fig. 3. Anti-prion activity of compounds and capture of CWD prions from biological 
samples using slice cultures 
(A) The anti-prion activity of compounds Astemizole, Congo red and Quinacrine. The percent 
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seeding ratios for CWD prions were tested in log dilutions (5ng, 0.5 ng, 50 pg shown as Grey 
orange and purple bars respectively). When the reactions were seeded with 5ng of seed, Congo 
red was able to reduce the seeding by 75% of the wells while Astemizole and Quinacrine 
treated slices have similar seeding ability like CWD infected controls. A similar trend is 
observed when the reactions were seeded with 0.5ng of the lysate. Inhibitory activity was 
observed for Quinacrine and Congo red when the reactions seeded contain 50pg of the seed 
while Astemizole has no apparent effect on the seeding activity of CWD prion-infected slice 
cultures. (B) CWD slices were exposed to recto-anal mucosa associated lymphoid tissue 
(RAMALT) samples to determine the prion propagation. The RAMALT homogenates were 
sterile filtered and 100 µg of this lysate is exposed to the 7-day old slices in culture media. The 
media was replaced with fresh media after 24 hours and cultured the slices for another 21 days. 
Traces represent the average seeding ability of these slices at different dilutions (50ng to 50pg) 
along with the CWD RAMALT sample. 50ng of the slices exposed to CWD infected 
RAMLAT sample had the highest seeding ability when followed by other seeding doses of 




Fig. 4. Transmission of CWD prions from slice cultures to mice inoculation 
(A) The 7-10 cerebellar slices from 42 dpi CWD infected and control cultures were pooled and 
washed twice in PBS. The pellet was resuspended in 60 µl of PBS by multiple and passages 
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through a 20-gauge needle and injected 30 µl into Tg12 mice. The CWD slices injected with 
had a lifespan of 208 days and displayed clinical signs before death. The mice infected with 
NBH slices had a lifespan of 477 days with no clinical signs before the endpoint. The brain 
homogenate from these mice were passaged again into Tg12 with an average lifespan of 139.5 
days demonstrating a reduced incubation period. (B) Traces represent the average of 4 
replicates from the reactions seeded with 5 µl the brain homogenate from the CWD slices 
infected Tg12 mice. (C) Immunohistochemistry of the paraffin-embedded tissue sections from 
multiple brain regions suggests neuropathology and CWD prion plaques. The sections of a 
negative control slice from thalamus devoid of such plaques were shown for comparison. 
Plaques were more abundant at the granular layer of the cerebellum, hippocampal formation. 
A diffuse pattern was observed in hypothalamus and medulla while a mixed pattern was 
manifested in midbrain and thalamus. Scale bars: 50 μm. 
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Abstract  
Converging evidence suggests that microglial dysfunction is a central player in the 
pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal dementia (FTD).  Risk 
factors such as metal exposure, pesticides, and peripheral inflammation (gut & lungs) have 
been implicated in the etiology of PD. The divalent metal Manganese (Mn) can cross the blood-
brain barrier and is linked to Parkinsonism. We hypothesized that Mn interacts synergistically 
with α-synuclein (α-syn) to trigger destructive neuroinflammatory processes. Therefore, we 
performed transcriptome analysis of microglia in response to Mn and α-syn and their co-
treatments to identify the key genes and signaling pathways underpinning the inflammatory 
response. We further validated the identified targets using quantitative real-time PCR and 
immunoblots. The α-syn treatment predominately activated innate immune response-related 
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genes involving cytokine and chemokine imbalances and their associated signaling pathways 
(TNF, NF-kB, and TLR signaling). In contrast, Mn caused distinct changes to pathways related 
to cellular senescence, NOD-like receptor signaling, apoptosis, HIF-1 signaling, and 
pyrimidine metabolism. Mn and α-syn co-treatment caused major perturbations in Rho GTPase 
signaling and inflammasome activation. Co-treatment also caused profound changes in 
transcripts that triggered microglia to switch to their more cytotoxic, M1 phenotype. Top 
upregulated genes were Il6, Urah, Nos2, Lcn2, and Csf3, while Slc14a1 transcripts were down-
regulated. Overall, our study identifies distinct genes and pathways elicited by α-syn and Mn 
that perturb microglial homeostasis. These findings also suggest that environmental factors can 
induce neuroimmune transformations that possibly alter the course of neurodegenerative 
processes. (Funding acknowledgment: NIH grants ES026892, NS088206, and W. Eugene 
Linda Lloyd Endowed Chair) 
 
Introduction  
Microglia play a pivotal role in maintaining protein homeostasis in neurodegenerative such as 
Parkinson’s and Alzheimer’s disease. Microglia are immune cells that reside in the central 
nervous system (CNS) and represent about 10% of cells. They have a key role in immune 
responses along with astrocytes that are typically triggered by receptor and ligand interaction. 
Despite their role in inflammation, microglial cells have been implicated in a variety of 
functions such as synaptic pruning, neuronal programmed cell death, synaptic plasticity and 
immunity in several CNS disorders. See this review for genes of interest (Salter et al., 2017). 
Unlike peripheral immune cells, microglia are traced to have originated from myeloid 
progenitors (RUNX1+/CD45-/C-Kit+) in the yolk-sac, then migrate to CNS. Since their early 
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embryonic development (E8.5 in mouse), they participate in CNS homeostasis. Microglia have 
unique ability to phagocytose and clear the protein aggregates, thus several studies are 
currently under investigation for therapeutic development. Growing evidence from genome-
wide association study GWAS studies from clinically confirmed FTD samples identified the 
immune function related genes (such as HLA on chromosome 6 are enriched) are increased 
(Broce et al., 2018). Mn neurotoxicity also termed as “manganism” has a resemblance to motor 
aspects of Parkinson’s disease. Mn is also shown to induce dopaminergic neurodegeneration 
and microglial activation. Additionally, maternal exposure to Mn induces activation of 
macrophages and microglia in the offspring rats. When dams were exposed at a dose of 800 
ppm, these rats have sustained inflammatory process as evidenced by the significant increase 
in the pro-inflammatory cytokines, Il1a, Il6, Nos2, and Tnf in the hippocampus when examined 
at 21 days after birth.(Abe et al., 2015) In a different study, postnatal (days 21–34) exposure 
to Mn (100 mg/Kg) by oral gavage and observed, reduction in the striatal dopamine, activation 
of NF-kB signaling and increased Nitrosative stress (Nos2 and 3NT) expression (Moreno et 
al., 2011). Microglia scavenge extracellular α-syn, thus making them an attractive target to 
develop therapeutic targets and to maintain protein homeostasis in CNS diseases (Lee et al., 
2008). For example, MHCII signaling complex was shown to be  required for activation of 
microglia in immune response to α-syn aggregates and was reported as a potential target for 
the development of neuroprotective therapies (Harms et al., 2013). Additionally, 
neuroinflammation and microglial response have been implicated in psychiatric disorders such 
as depression, bipolar disorder, schizophrenia, and autism (Reus et al., 2015). Metabolic 
reprogramming has been linked to the phenotypic classification of microglial polarity. The 
shift in the mode of energy production from oxidative phosphorylation to aerobic glycolysis is 
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linked to M1 phenotype suggesting mitochondrial metabolites drives the polarization state of 
microglia (Orihuela et al., 2016). Microglial activation induced by Mn was shown to precede 
and is responsible for preferential cell death in dopaminergic cells when compared to other 
neurons (Zhang et al., 2009). Another study demonstrates M1 state is responsible for 
detrimental effects on recovery in the injured CNS. This study also demonstrates that TNF 
prevents M1 to M2 state in spinal cord injury. The effect of another metal ion, Iron is known 
to create unfavorable inflammation as it switches cells from M2 to M1 phenotype (Kroner et 
al., 2014). Microglial senescence leads to impaired ability to clear the myelin debris by 
phagocytic dysfunction and preventing this can be a promising target. Cell culture models and 
primary cells have improved understanding of the microglial biology and remain to be the 
major neurodegenerative models to study CNS diseases. In this study, we used RNA-
Sequencing to characterize changes in the mRNA profile of microglial response when treated 
with Mn, α-syn and their co-treatment. Based on expression levels of these transcriptome-wide 
analysis, we provide key mechanisms or pathways that alters microglial homeostasis in 
clearing aggregates or counter neurotoxicity. 
Results 
Innate immune response leading to cytokine signaling in microglia is triggered by 
misfolded α-syn 
Microglial cells were exposed to misfolded α-syn for 24 hours and the transcriptome analysis 
was performed to identify the differentially expressed mRNAs. Genes are grouped based on 
the differential expression of genes. Fig. 1A shows volcano plots of the genes that are 
differentially expressed in response to misfolded α-syn treatment. A total of 840 genes were 
upregulated and 890 genes were downregulated. The genes shown in red dots were 
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upregulated. Some of these top increased gene changes were Il6, Lcn2, Fpr1, Il1b, Slfn1(>300 
fold); Csf3, Bcl2a1a, Il1a, Nos2 (>150 fold); Adh7, Cxcl3, Gstt4, Urah (>150 fold); Most of 
these genes are implicated in cytokine signaling, release, and receptor binding event that 
triggers a typical innate immune response. The genes shown in green dots were downregulated 
genes. The top genes that are downregulated are Cecr6 (>150 fold); Ocstamp, Serpinb1a, 
Tspan10, Sema4g (>20 fold); Klhl38, Hpgd, Slc14a1, Gm5086, Camk2b, Cd24a, Asb10, Lifr, 
Cx3cr1 (>10 fold); The genes with top changes and their associated p-values are listed under 
supplementary Table 1. Fig. 1B&C shows heat maps of the top 50 genes that are differentially 
expressed and major pathways in response to α-syn treatment. Genes that are upregulated are 
shown in red and the genes that are downregulated are shown in green. 
Manganese treatment alters transcriptomic changes in microglial cells that lead to 
microglial senescence.  
Manganese has been implicated in the microglia-mediated neurodegeneration. Microglia were 
exposed to 100 µM Mn for 24 hours and the transcriptome analysis identifies differentially 
expressed genes that are unique to Manganese neurotoxicity. Based on the differential 
expression of genes, volcano plots of the genes that are differentially expressed in response to 
Mn treatment were shown in Fig. 2A. A total of 2236 gene were upregulated, and 2196 genes 
were downregulated. The genes shown in red dots were upregulated. Some of the top gene 
changes were Gsta2, Sstr5, Adh7, H2-Q9 (~200-250-fold increase); Vat1l, Car6, Tnfsf4, 
Agpat9, Dio2, Spta1(~100-fold increase); Rtn4r, Cd207, Osbp2, Calcb, Rhpn2, Wnt9a, Ptgs2, 
Avil, Mmp13, Il6, Mmp10 (>50-fold increase). The genes that were downregulated are 
represented as shown in green dots. The top genes that are downregulated are Cx3cr1, Asb10, 
Kmo, Ttn, Abca9, Sema4g, Ankle1, Tlr2, Pif1, Hist1h2ao (7-15-fold decrease). However, there 
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is a profound downregulation in haptoglobin gene (78 fold) that has been implicated in 
neuroprotection following intracerebral hemorrhage (Garton et al., 2017a). The genes with top 
fold changes and least p-values are listed under supplementary Table 2. Fig. 2B&C shows heat 
maps of the top 50 genes that are differentially expressed and major pathways in response to 
misfolded α-syn treatment. Genes that are upregulated are shown is red and the genes that are 
downregulated are shown in green. 
Manganese and misfolded α-syn synergistically alters transcriptomic landscape of the 
microglial cells to promote cytotoxic signaling  
α-syn interacts with Mn both in-vitro and in in-vivo. To determine the precise effects of the 
Mn binding to misfolded α-syn, microglia were co-treated, and the transcriptome profile is 
analyzed. The differential expression of genes was plotted and shown in Fig. 3A. A total of 
2237 gene were significantly upregulated but over half of the transcripts are unique to the co-
treatment when compared to individual treatments alone. The genes shown in red dots were 
upregulated. We found some of the top gene changes were associated with activation of 
microglia that leads to subsequent cytotoxic signaling. A striking increase was noted in the 
following genes - Il6 (3400 fold), Urah (1450 fold), Nos2, Lcn2 Csf3 (> 1000-fold); Other 
genes that were upregulated are Il12b, Adh7, Il1b, Mmp3, Il1f6 (> 500-fold); Slfn1, Ptgs2os, 
Serpinb2, Cxcl3, Il1a, Bcl2a1a, H2-Q9, Ptgs2, Sstr5 (> 200-fold increase); Transcripts of the 
genes that are involved in chemokine and cytokine signaling are abundantly increased (>100 
fold). Mn caused major perturbations in the transcripts of Rho-GTPases signaling, their 
effectors, and cell cycle regulation (Fig.2C). Some of these top genes are Ccl5, Cxcl2, Mmp13, 
Ifnb1, Cemip, Plagl1, Traf1, Tmc7, Dio2, Pydc4, Mmp10, Rsad2, Ggt1, Upp1. Transcripts 
related to innate defense such as Interferon signaling are also abundantly expressed. Pgf, Lif, 
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Rgs9, Tpbg, Gpr126, Procr, Zbp1, Tnn, Rtn4r, Isg15, Car6, Spta1, Osbp2, Agpat9, Ifit3 
showed > 50-fold increased. In addition to the upregulated genes, misfolded α-syn and Mn co-
treatment caused some dramatic change in the transcripts that are down-regulated. Slc14a1, (a 
solute carrier family 14 - urea transporter), has 110-fold decrease suggesting proteins for neural 
transmitter recycling are decreased. Other genes that are downregulated are Serpinb1a, Hp, 
Abca9, Armc2, Ppfia4, Kmo, Hpgd, Asb10, Xkr5, Kcne3. Fig. 3B shows a heat map of top 50 
transcripts that are upregulated (red) and downregulated (green) upon co-treatment of Mn and 
misfolded α-syn while Fig. 3C represents major pathways and biological process affected. The 
genes with top fold changes are listed under Table 1. 
Mn and misfolded α-syn alter distinct pathways that alter microglial function 
M1 and M2 phenotypic alteration in the microglia contributing either to a cytotoxic function 
or immunomodulatory roles respectively are increasingly being accepted for functional 
description. We have examined the transcripts to determine if there is any functional alteration. 
Interestingly, we observed that Mn and misfolded α-syn co-treatment caused a profound 
activation of M1-Cytotoxic phenotype (Fig. 4B). Such unanimous changes in the pro-
inflammatory genes were not profound when either of the treatments was done alone. Top 
upregulated genes based on the magnitude of fold changes in the transcripts with respect to 
either of the treatments was shown in Table 1. Majority of pathways are related to innate 
immunity and stress response pathways in microglia. The Venn diagram (Fig. 4A) shows 
significantly different genes that are either converging and unique to each treatment. When 
microglial cells were treated with misfolded α-syn, a total of 232 genes are significantly 
different that are unique to this treatment. Other significantly different genes, 85 genes related 
to Mn treatment only group and 399 genes are overlapping with the co-treatment group and 
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1014 genes that are significantly different in all three treatments. Similarly, 914 genes 
differentially expressed and unique Mn treatment alone and 1024 for co-treatment. However 
about 2419 genes that are differentially expressed overlap for Mn and co-treatment.  
Discussion 
We have systemically characterized the transcriptome of microglia in response to the 
neurotoxicant Manganese, misfolded α-syn, and their co-treatment. While microglia are shown 
to play important role in tackling the misfolded α-syn, and Mn neurotoxicity, how microglia 
responds to these stimuli are not characterized. Microglia have been shown to efficiently clear 
extracellular α-syn with concurrent activation of TLR signaling and CX3CL1– CX3CR1 
signaling deficits (Thériault et al., 2016). This inherent ability of microglia to protect CNS in 
neurodegeneration as a phenomenon being explored as druggable target (Sanchez-Guajardo et 
al., 2015). Using RNA sequencing, we identified pathways and genes involved in this context. 
We corroborated the sequencing data using a panel of key genes involved using qRT-PCR, 
Immunoblotting (dot blots), and immunocytochemistry. A comprehensive study characterized 
the transcripts that are enriched in microglia and other cell types in the brain (Zhang et al., 
2014). The current transcriptome analysis identified majority of the transcripts are expressed 
(32/34 genes matched). Transcriptome profiling of misfolded α-syn responsive genes are 
associated with major biological perturbations related to cellular responses to cytokines and 
their receptors, inflammation, positive response to cell motility, protein trafficking, DNA 
binding, reactive oxygen species and activation of pathways such as MAPK cascade leading 
to a phagocytic phenotype. On the other hand, Mn-induced major changes in biological 
pathways related to cell cycle, cytokine response, transferase activity, regulation of cellular 
protein localization, protein serine/threonine kinase activity, phase separation, oxidative stress, 
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intrinsic apoptosis, cell adhesion. Interestingly, RNA processing such as RNP complex 
biogenesis, protein and nitrogen catabolism and innate immune responses were altered. The 
co-treatment of Mn and misfolded α-syn resulted in changes in the much larger pool of 
transcripts related to innate immunity, cytokine signaling, modification-dependent protein 
catabolic process, activation of protein kinases, oxidative stress, and DNA replication. 
Additionally, TNF signaling appears to be a major player in the co-treatment as evidenced by 
immunoblots. Similarly, elevated levels of TNF-alpha2 have been reported to be a principal 
feature of CSF from FTD patients(Broce, et al., 2018). Another study demonstrated IFN milieu 
downregulates microglial myocyte-specific enhancer factor 2C (Mef2C) (Deczkowska et al., 
2017) that leads to inflated microglial response and subsequent adverse behavior in mice. Mn 
caused downregulation of Mef2C and thus might be contributing to the hostile microglial 
response to α-syn. IFN gamma is known to restrict innate, protective cells thereby increasing 
the susceptibility to influenza virus (Califano et al., 2018). We observed misfolded α-syn 
activated IFN gamma signaling may play a detrimental role in the pathogenesis that may lead 
to microglial dysfunction and neuronal damage. Another report suggested glial activation in 
the neuroinflammatory process is mediated by NOS2 expression during Mn exposure (Streifel 
et al., 2012). Similarly, we find striking upregulation in the RNA and protein levels of NOS2 
suggesting Mn exacerbates the 3-nitrotyrosine protein adducts. Mn also triggered profound 
changes in signaling by Rho-GTPases (Fig. 2C). This effect is even exacerbated with the 
misfolded α-syn co-treatment (Fig. 3C). Rho signaling has a major link to cell motility, actin 
dynamics, and vesicular trafficking (Ridley). Therefore, we speculate that Mn may affect 
microglial motility, membrane protrusions, thereby altering the microglial phagocytic ability 
to clear protein aggregates.  
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Despite our efforts to obtain a clear picture of transcriptome from microglia in culture, the 
brain remains to be the more complex environment. For example, Pu.1 and Irf8 genes, that are 
lineage-specific differentiate microglia from tissue-resident macrophages. In the current study, 
Irf8 but not Pu.1 transcripts are detected in the current transcriptome dataset. However, based 
on the transcriptome profiling of different brain cell types in another study (Mathys et al., 
2017; Zhang, et al., 2014), most transcripts that are enriched specifically in the microglia are 
detected in our transcriptome analysis (see Supplementary Table 8). Further, we list the major 
changes associated with genes (at least 5-fold changes) were listed in supplementary tables 2-
6. Developing novel tools such as organotypic models such as OSCAR model (Kondru et al., 
2017b) would be a superior advantage to study misfolded α-syn induced neurotoxicity. We are 
currently investigating the some of these findings in the slice culture model of α-syn prions. 
Overall, our findings provide novel insights into global transcriptome responses with microglia 
that open the door for identifying targets governing microglial homeostasis.  
 
Materials and Methods 
Cell culture and treatments 
Mouse microglial cell line was a gift from Douglas T Golenbock (U Mass) and cultured as 
described previously. (Halle et al., 2008). These immortalized microglial cells showed absolute 
purity and resembled primary microglia in both morphology and surface expression markers 
such as CD11b+ and CD14+, CD45+, MHCII, CD11c, and F4/80. (See supplementary fig 1 in 
the cited paper). Further, these cells responded to ATP and amyloid beta with larger soma and 
amoeboid morphology and expression of Nitric oxide, TNF and IL-1beta expression levels that 
match primary microglia. Cells were maintained in DMEM:F12 media supplemented with 9% 
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FBS, penicillin/streptomycin, glutamine, and sodium pyruvate and treatments were done with 
serum excluded. 
RNA seq and analysis 
Total RNA was extracted using the Trizol reagent (Ambion) from three biological replicates 
of mouse microglia that are in 4-6th passage. The RNA concentration was measured with 
Nanodrop (Thermo Fisher Scientific, Waltham, MA). RNA-Seq was performed with poly-A 
enrichment method. Next, the cDNA libraries for RNA-seq samples were constructed and 
sequenced. Before library construction, samples were spiked with Ex-Fold External RNA 
Consortium controls (Ambion, Foster City, CA). Libraries then underwent deep sequencing to 
20 million reads of length 150 base pairs, paired-end sequencing.  
Quantitative real-time PCR (qRT-PCR)  
qRT-PCR was performed as described previously (Ay et al., 2017) (Kim et al., 2017). Total 
RNA from the cells was extracted using Trizol reagent (Invitrogen). RNA was quantified using 
Nanodrop and converted to cDNA using the High Capacity cDNA Synthesis kit (Life 
Technologies). PCR was performed according to the manufacturer’s protocol. Validated 
primers (Qiagen) were used for detecting the mRNA of target genes. For housekeeping gene 
controls, Validated primers of 18S rRNA and GAPDH were used. The threshold cycle (Ct) 
result was adjusted and fold change in gene expression was calculated using the delta-delta Ct 
method. 
Dot Blot 
Immunoreactivity of samples was determined by dot-blot using Bio-Dot® Microfiltration 
System using manufacturer’s protocol as described previously (Sun, et al., 2005). In brief, 
microglial lysates were prepared, and protein concentrations were determined as described 
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above. Next, 0.5 μg of lysates were mixed with 200 μl of Tris-buffered saline (1X TBS) having 
0.1% Tween-20. After incubation, samples were allowed to adsorb onto a nitrocellulose 
membrane for 1 h. The membrane was washed twice with 200 μl of 1X TBS using a gentle 
vacuum, blocked with 1X LBB for 30 min, incubated with primary and secondary antibodies 
as described previously (Kondru, et al., 2017a).  
Recombinant protein expression and purification  
Recombinant alpha-α-syn and prion proteins were expressed and purified using previously 
reported protocols (Atarashi, et al., 2008; Orru, et al., 2011; Vascellari, et al., 2012; West 
Greenlee, et al.; Wilham, et al., 2010). Recombinant alpha-α-syn was prepared using size 
exclusion followed by anion exchange chromotography. Step by step protocols are provided 
in the supplemental info. Each batch was routinely tested for quality and activity using 
Coomassie and Western blot. 
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Table 1. Top differentially expressed and upregulated genes when microglial cells when 





Gene Name α-syn Mn Syn+ 
Mn 
Implications Ref  









4 6 788 p40 subunit activates NF-κB 
leading to iNOS expression 
(Pahan et al., 
2001) 
Nos2 nitric oxide 
synthase 2, 
inducible 
180 25 1141 Proinflammatory, Oxidative 
stress, Neurobehaviour 
(Kurland et al., 
2016; Straccia et 
al., 2011; 






237 8 1099 Proinflammatory, Jak-STAT 
signaling, proliferation 
(Gonzalez-Pena 




7 6 629 Pro-inflammatory activation, 
Correlates with Huntington 
disease severity 
(Connolly et al., 
2016) 
Il1f6 interleukin 1 
family, 
member 6 
37 6 513 inflammasome activation, 
Stress induced deficits and 
inflammation 
(Giulian et al., 
























46 40 293 Proteostasis during protein 
misfolding, Cryoprotection 




43 4 181 Calcium influx, Pro-
inflammatory, Microglial 
growth factor 
(Shideman et al., 






14 16 138 Unknown 
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37 13 174 P2X7 receptor stimulation 
and PKC AMPK signaling 
activation 












25 58 222 Inflammation, Cox-2/Ptgs2 
activation leads to cytotoxic 
(M1-like) phenotype 







14 15 110 late response activation gene 
in neurodegeneration; 
Defense response to virus; 
Essential for Golgi 
trafficking of TNF-α 
(Chung et al., 
2011; Mathys, et 
al., 2017) 
Cemip cell migration 
inducing 
protein 
23 17 128 Unknown 
 
Lcn2 lipocalin 2 510 34 1134 M1 polarization of activated 
microglia is amplified; 
autocrine signal in 
ramification and apoptosis 
(Jang et al., 






36 5 123 Apoptosis, FADD to the 
TNFR1 complex mediates 
apoptosis 
(Hsu et al., 1995; 




22 13 100 Microglial activation by P2Y 
receptors. Increased 
phagocytotic activity in 
microglia 
(Haynes et al., 
2006; Ransohoff 











9 56 156 Inflammation resulting 
neuronal loss, Protease with 
broad substrate specificity 
(Hugenberg et 




















125 17 278 Chemokine binds to CXCR2, 
migration, and adhesion  
(Farioli-





-1 63 108 Glutathione metabolism, 
Superoxide generation,  
(Roy et al., 





 Table 1. (continued)   
Il1b interleukin 1 
beta 
345 4 664 Proinflammatory, 
Inflammasome 
(Sanchez-
Guajardo, et al., 
2015; Stojakovic 





9 71 121 Unknown 
 
Pydc4 pyrin domain 
containing 4 
50 41 119 Inflammasome (Ratsimandresy 
et al., 2013) 
Adh7 alcohol 
dehydrogenas
e 7 (class IV), 
mu or sigma 
polypeptide 




e, type II 
12 95 121 Unknown 
 
Il1a interleukin 1 
alpha 
190 6 269 Pro-inflammatory (Das et al., 2016; 









229 6 242 Apoptosis, Prion mediated 
neurodegeneration 





bility 2, Q 
region locus 9 
67 191 231 Unknown, Speculated for 
Microglial activation. 
(Imamura et al., 
2003) 
Slfn1 schlafen 1 317 68 465 Unknown, Microglial 
activation? 
(Boutej et al.) 
Sstr5 somatostatin 
receptor 5 
15 260 202 Phagocytosis of amyloid 
aggregates, inhibition of 
cAMP, tyrosine 
phosphorylation 
(Carniglia et al., 
2017; Fleisher-
Berkovich et al., 
2010) 
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-5 -3 -108 Modulates Kv3.1 and 
Kv2.1channel activity 
(McCrossan 
et al., 2003) 
Nptxr neuronal pentraxin 
receptor 
-4 -1 -91 Removal of debris from the 
synaptic space, 
downregulated in oxidative 
stress and PD 
(Anantharam 
et al., 2007; 
Thomas et 
al., 2006) 
Xkr5 X Kell blood group 
precursor-related 
family, member 5 
-2 -6 -85 Unknown  
Asb10 ankyrin repeat and 
SOCS box-containing 
10 
-16 -12 -81 Unknown   
Pira4 paired-Ig-like 
receptor A4 




















-1 -12 -45 tryptophan metabolism (Zwilling et 
al., 2011) 
Ppfia4 protein tyrosine 
phosphatase, receptor 
type, f polypeptide 
(PTPRF), interacting 
protein (liprin), alpha 
4 




(Katoh et al., 
2003) 
Armc2 armadillo repeat 
containing 2 
-9 -6 -41 unknown  
Abca9 ATP-binding 
cassette, sub-family 
A (ABC1), member 9 
-3 -8 -36 monocyte differentiation 
into macrophages, 
cholesterol-responsive 
(Piehler et al., 
2002) 
Hp haptoglobin -2 -79 -36 Neuroprotection (Deuel et al., 
2015; Garton 
et al., 2017b) 
Serpinb
1a 
serine (or cysteine) 
peptidase inhibitor, 
clade B, member 1a 
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Supplementary table 1: Misfolded α-Synuclein treatment caused upregulation in the 
genes in microglia >5 fold 
Gene Name Fold 
Change 
Il6 interleukin 6 714 
Lcn2 lipocalin 2 510 
Fpr1 formyl peptide receptor 1 364 
Il1b interleukin 1 beta 345 
Slfn1 schlafen 1 317 
Csf3 colony stimulating factor 3 (granulocyte) 237 
Bcl2a1a B cell leukemia/lymphoma 2 related protein A1a 229 
Il1a interleukin 1 alpha 190 
Nos2 nitric oxide synthase 2, inducible 180 
Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 133 
Cxcl3 chemokine (C-X-C motif) ligand 3 125 
Gstt4 glutathione S-transferase, theta 4 108 
Urah urate (5-hydroxyiso-) hydrolase 103 
Pydc4 pyrin domain containing 4 50 
Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, member 2 46 
Ccl5 chemokine (C-C motif) ligand 5 43 
Fpr2 formyl peptide receptor 2 38 
Cxcl2 chemokine (C-X-C motif) ligand 2 37 
4921529L05
Rik 
RIKEN cDNA 4921529L05 gene 36 
Zbp1 Z-DNA binding protein 1 36 
Traf1 TNF receptor-associated factor 1 36 
Ccl12 chemokine (C-C motif) ligand 12 28 
Irg1 immunoresponsive gene 1 26 
Ptgs2 prostaglandin-endoperoxide synthase 2 25 
Upp1 uridine phosphorylase 1 22 
Cxcl10 chemokine (C-X-C motif) ligand 10 20 
6530402F18
Rik 
RIKEN cDNA 6530402F18 gene 19 
Ly6a lymphocyte antigen 6 complex, locus A 18 
Zfp811 zinc finger protein 811 17 
Pyhin1 pyrin and HIN domain family, member 1 17 
Isg15 ISG15 ubiquitin-like modifier 17 
Tarm1 T cell-interacting, activating receptor on myeloid cells 1 16 
AA467197 expressed sequence AA467197 16 
Saa3 serum amyloid A 3 16 
Pydc3 pyrin domain containing 3 15 
Gm5483 predicted gene 5483 14 
Rsad2 radical S-adenosyl methionine domain containing 2 14 
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Supplementary table 1 (continued)   
Tnn tenascin N 14 
Ccl7 chemokine (C-C motif) ligand 7 13 
Gbp5 guanylate binding protein 5 13 
Ifit3 interferon-induced protein with tetratricopeptide repeats 3 13 
Lipg lipase, endothelial 12 
Hdc histidine decarboxylase 12 
Avil advillin 12 
Ifit1 interferon-induced protein with tetratricopeptide repeats 1 11 
Edn1 endothelin 1 11 
Isg20 interferon-stimulated protein 11 
Pilrb1 paired immunoglobin-like type 2 receptor beta 1 11 
Aqp9 aquaporin 9 10 
Fam171b family with sequence similarity 171, member B 10 
Apol9b apolipoprotein L 9b 10 
Procr protein C receptor, endothelial 10 
Socs2 suppressor of cytokine signaling 2 10 
Mmp13 matrix metallopeptidase 13 9 
Tgm1 transglutaminase 1, K polypeptide 9 
Lix1 limb expression 1 homolog (chicken) 9 
Socs3 suppressor of cytokine signaling 3 9 
Gbp7 guanylate binding protein 7 9 
Gbp4 guanylate binding protein 4 9 
2010005H15
Rik 




Osbp2 oxysterol binding protein 2 9 
Mx2 MX dynamin-like GTPase 2 9 
Apol9a apolipoprotein L 9a 9 
Thbs1 thrombospondin 1 8 
9430076C15
Rik 
RIKEN cDNA 9430076C15 gene 8 
Cish cytokine inducible SH2-containing protein 8 
Gbp2 guanylate binding protein 2 8 
Gbp3 guanylate binding protein 3 8 
Lif leukemia inhibitory factor 8 
Ifi44 interferon-induced protein 44 8 
Gm14446 NA 8 
Cmpk2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial 8 
Irf7 interferon regulatory factor 7 8 
Agpat9 1-acylglycerol-3-phosphate O-acyltransferase 9 7 
Trim30d tripartite motif-containing 30D 7 
Mnda myeloid cell nuclear differentiation antigen 7 
Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 7 
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Supplementary table 1 (continued) 
Mx1 MX dynamin-like GTPase 1 7 
Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B cells 
inhibitor, zeta 
7 
Ddit3 DNA-damage inducible transcript 3 6 
Klra2 killer cell lectin-like receptor, subfamily A, member 2 6 
Slamf7 SLAM family member 7 6 
Gpr31b G protein-coupled receptor 31, D17Leh66b region 6 
Ifit2 interferon-induced protein with tetratricopeptide repeats 2 6 
Il1rn interleukin 1 receptor antagonist 6 
Msr1 macrophage scavenger receptor 1 6 
Ccl2 chemokine (C-C motif) ligand 2 6 
Angptl3 angiopoietin-like 3 6 
Pou2f2 POU domain, class 2, transcription factor 2 6 
Pla1a phospholipase A1 member A 6 
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 6 
F5 coagulation factor V 6 
Gm4070 predicted gene 4070 6 
Pilra paired immunoglobin-like type 2 receptor alpha 6 
Hid1 HID1 domain containing 6 
Ptger2 prostaglandin E receptor 2 (subtype EP2) 6 
Oasl2 2'-5' oligoadenylate synthetase-like 2 6 
Ifi204 interferon activated gene 204 6 
Lta lymphotoxin A 6 
Oasl1 2'-5' oligoadenylate synthetase-like 1 6 
Slc15a3 solute carrier family 15, member 3 6 
Wfdc17 WAP four-disulfide core domain 17 6 
Cdcp1 CUB domain containing protein 1 5 
Zc3h12a zinc finger CCCH type containing 12A 5 
Usp18 ubiquitin specific peptidase 18 5 
Trem1 triggering receptor expressed on myeloid cells 1 5 
Nox1 NADPH oxidase 1 5 
Fcgr1 Fc receptor, IgG, high affinity I 5 




Supplementary table 2: Misfolded α-Synuclein treatment caused downregulation in the 
genes in microglia >5 fold 
Gene Name Fold 
Change 
Cecr6 cat eye syndrome chromosome region, candidate 6 -179 
Sema4g sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cytoplasmic domain, (semaphorin) 4G 
-54 
Tspan10 tetraspanin 10 -46 
Serpinb1a serine (or cysteine) peptidase inhibitor, clade B, member 1a -25 
Ocstamp osteoclast stimulatory transmembrane protein -22 
Cx3cr1 chemokine (C-X3-C motif) receptor 1 -17 
Lifr leukemia inhibitory factor receptor -16 
Asb10 ankyrin repeat and SOCS box-containing 10 -16 
Cd24a CD24a antigen -14 
Camk2b calcium/calmodulin-dependent protein kinase II, beta -14 
Gm5086 predicted gene 5086 -12 
Slc14a1 solute carrier family 14 (urea transporter), member 1 -12 
Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) -12 
Klhl38 kelch-like 38 -12 
Fcrls Fc receptor-like S, scavenger receptor -10 
Klrd1 killer cell lectin-like receptor, subfamily D, member 1 -9 
Srpk3 serine/arginine-rich protein specific kinase 3 -9 
Pdk2 pyruvate dehydrogenase kinase, isoenzyme 2 -9 
Armc2 armadillo repeat containing 2 -9 
Pacsin1 protein kinase C and casein kinase substrate in neurons 1 -8 
Mn1 meningioma 1 -8 
Gpr162 G protein-coupled receptor 162 -7 
Cmbl carboxymethylenebutenolidase-like (Pseudomonas) -7 
Pianp PILR alpha associated neural protein -6 
Lsp1 lymphocyte specific 1 -6 
Crip1 cysteine-rich protein 1 (intestinal) -6 
Ppfia4 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), 
interacting protein (liprin), alpha 4 
-6 
Lrrc14b leucine rich repeat containing 14B -6 
Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 -5 
Kcne3 potassium voltage-gated channel, Isk-related subfamily, gene 3 -5 
9330188P
03Rik 
RIKEN cDNA 9330188P03 gene -5 
Aif1 allograft inflammatory factor 1 -5 
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Supplementary table 3: Manganese treatment caused upregulation in the genes in 
microglia >5 fold 
Gene Name Fold 
change 
Gsta2 glutathione S-transferase, alpha 2 (Yc2) 265 
Sstr5 somatostatin receptor 5 260 
Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 247 
H2-Q9 histocompatibility 2, Q region locus 9 191 
Vat1l vesicle amine transport protein 1 homolog-like (T. californica) 151 
Car6 carbonic anhydrase 6 145 
Tnfsf4 tumor necrosis factor (ligand) superfamily, member 4 113 
Agpat9 1-acylglycerol-3-phosphate O-acyltransferase 9 107 
Dio2 deiodinase, iodothyronine, type II 95 
Spta1 spectrin alpha, erythrocytic 1 92 
Rtn4r reticulon 4 receptor 86 
Cd207 CD207 antigen 84 
Osbp2 oxysterol binding protein 2 71 
Calcb calcitonin-related polypeptide, beta 66 
Rhpn2 rhophilin, Rho GTPase binding protein 2 65 
Wnt9a wingless-type MMTV integration site family, member 9A 62 
Ptgs2 prostaglandin-endoperoxide synthase 2 58 
Avil advillin 58 
Mmp13 matrix metallopeptidase 13 56 
AA467197 expressed sequence AA467197 52 
Il6 interleukin 6 52 
Mmp10 matrix metallopeptidase 10 48 
Myc myelocytomatosis oncogene 45 
Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 44 
Nptx1 neuronal pentraxin 1 44 
Myo7b myosin VIIB 41 
Pgf placental growth factor 41 
Ccbe1 collagen and calcium binding EGF domains 1 41 
Pydc4 pyrin domain containing 4 41 
Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, member 2 40 
Rgs9 regulator of G-protein signaling 9 40 
Prph peripherin 39 
Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 36 
Akap2 A kinase (PRKA) anchor protein 2 36 
Lcn2 lipocalin 2 34 
Mt3 metallothionein 3 34 
Ccdc136 coiled-coil domain containing 136 33 
Slc16a14 solute carrier family 16 (monocarboxylic acid transporters), member 14 32 
Stbd1 starch binding domain 1 32 
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Cdcp1 CUB domain containing protein 1 30 
Dthd1 death domain containing 1 29 
Ddit3 DNA-damage inducible transcript 3 27 
5031410I06
Rik 
RIKEN cDNA 5031410I06 gene 26 
Efcab6 EF-hand calcium binding domain 6 26 
Nyap2 neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 26 
Procr protein C receptor, endothelial 26 
Rgs16 regulator of G-protein signaling 16 25 
Dusp1 dual specificity phosphatase 1 25 
A530064D0
6Rik 
RIKEN cDNA A530064D06 gene 25 
Dusp8 dual specificity phosphatase 8 25 
Nos2 nitric oxide synthase 2, inducible 25 
Dusp5 dual specificity phosphatase 5 25 
Lif leukemia inhibitory factor 24 
Fam171b family with sequence similarity 171, member B 24 
Mylk2 myosin, light polypeptide kinase 2, skeletal muscle 23 
Gpr126 NA 23 
Pxdc1 PX domain containing 1 22 
Gprc5a G protein-coupled receptor, family C, group 5, member A 21 
Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-
terminal domain 1 
20 
Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate 
transporter, system Xag), member 1 
20 
Itga3 integrin alpha 3 20 
Cdkn1c cyclin-dependent kinase inhibitor 1C (P57) 19 
Gadd45a growth arrest and DNA-damage-inducible 45 alpha 19 




Adm adrenomedullin 18 
Gbp8 guanylate-binding protein 8 18 
Nox3 NADPH oxidase 3 18 
Pira11 paired-Ig-like receptor A11 18 
Isg20 interferon-stimulated protein 17 
Ifit3 interferon-induced protein with tetratricopeptide repeats 3 17 
Pydc3 pyrin domain containing 3 17 
Lat linker for activation of T cells 16 
Trib3 tribbles homolog 3 (Drosophila) 16 
Gsta3 glutathione S-transferase, alpha 3 16 
Gm20594 predicted gene, 20594 16 
Ntn1 netrin 1 16 
2010005H1
5Rik 
RIKEN cDNA 2010005H15 gene 16 
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Supplementary table 3 (continued) 
Gm5483 predicted gene 5483 16 
Rhov ras homolog gene family, member V 16 
Sccpdh saccharopine dehydrogenase (putative) 15 
Jag1 jagged 1 15 
Apol9b apolipoprotein L 9b 15 
Lamc2 laminin, gamma 2 15 
Bcar1 breast cancer anti-estrogen resistance 1 15 
Rsad2 radical S-adenosyl methionine domain containing 2 15 
Fam71f2 family with sequence similarity 71, member F2 14 
Abcb9 ATP-binding cassette, sub-family B (MDR/TAP), member 9 14 
Neurl1a neuralized E3 ubiquitin protein ligase 1A 14 
Gdf15 growth differentiation factor 15 14 
Hid1 HID1 domain containing 14 
Rph3al rabphilin 3A-like (without C2 domains) 13 
Grb10 growth factor receptor bound protein 10 13 
Csn3 casein kappa 13 
Pfn2 profilin 2 13 
Prkg2 protein kinase, cGMP-dependent, type II 13 
Fignl2 fidgetin-like 2 13 
Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 13 
Plat plasminogen activator, tissue 13 
Cxcl2 chemokine (C-X-C motif) ligand 2 13 
Upp1 uridine phosphorylase 1 13 
Ndrg1 N-myc downstream regulated gene 1 13 
Spns2 spinster homolog 2 12 
Rhou ras homolog gene family, member U 12 
B230312C0
2Rik 
RIKEN cDNA B230312C02 gene 12 
Epha2 Eph receptor A2 12 
Aqp9 aquaporin 9 12 
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 12 
Fcrlb Fc receptor-like B 12 
Arg1 arginase, liver 12 
Tarm1 T cell-interacting, activating receptor on myeloid cells 1 11 
Gm13889 predicted gene 13889 11 
Wwc1 WW, C2 and coiled-coil domain containing 1 11 
Cox6a2 cytochrome c oxidase subunit VIa polypeptide 2 11 
Akr1b7 aldo-keto reductase family 1, member B7 11 
Pyhin1 pyrin and HIN domain family, member 1 10 
P4ha2 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), alpha II polypeptide 
10 
Src Rous sarcoma oncogene 10 
1700030J22
Rik 
RIKEN cDNA 1700030J22 gene 10 
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Cd22 CD22 antigen 10 
Gfod1 glucose-fructose oxidoreductase domain containing 1 10 
Ptger2 prostaglandin E receptor 2 (subtype EP2) 10 
F2rl2 coagulation factor II (thrombin) receptor-like 2 10 
Lrrc32 leucine rich repeat containing 32 10 
Apol9a apolipoprotein L 9a 10 
Isg15 ISG15 ubiquitin-like modifier 9 
Ifit1 interferon-induced protein with tetratricopeptide repeats 1 9 
Mt2 metallothionein 2 9 
Cnga3 cyclic nucleotide gated channel alpha 3 9 
Rbpms2 RNA binding protein with multiple splicing 2 9 
Scg2 secretogranin II 9 
Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) 9 
Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 9 
Bean1 brain expressed, associated with Nedd4, 1 9 
Ccl22 chemokine (C-C motif) ligand 22 9 
Sema3e sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3E 
9 
Mgam maltase-glucoamylase 9 
Acsbg1 acyl-CoA synthetase bubblegum family member 1 9 
Ifi44 interferon-induced protein 44 8 
Angptl6 angiopoietin-like 6 8 
Ccl12 chemokine (C-C motif) ligand 12 8 
Sesn3 sestrin 3 8 
Nupr1 nuclear protein transcription regulator 1 8 
Notch4 notch 4 8 
Mmp12 matrix metallopeptidase 12 8 
B430306N0
3Rik 
RIKEN cDNA B430306N03 gene 8 
Slc35f1 solute carrier family 35, member F1 8 
Il1f9 interleukin 1 family, member 9 8 
Col20a1 collagen, type XX, alpha 1 8 
Smyd1 SET and MYND domain containing 1 8 
Gprc5b G protein-coupled receptor, family C, group 5, member B 8 
Plekhg1 pleckstrin homology domain containing, family G (with RhoGef 





Ptprn protein tyrosine phosphatase, receptor type, N 8 
Csf3 colony stimulating factor 3 (granulocyte) 8 
Lix1 limb expression 1 homolog (chicken) 8 
Nyap1 neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 8 
Adcy3 adenylate cyclase 3 7 
Gm10220 predicted gene 10220 7 
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Cd274 CD274 antigen 7 
Stk40 serine/threonine kinase 40 7 
Pdlim7 PDZ and LIM domain 7 7 
Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B cells 
inhibitor, zeta 
7 
Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 11 
7 
Cdon cell adhesion molecule-related/down-regulated by oncogenes 7 
Atp13a4 ATPase type 13A4 7 
Fgf9 fibroblast growth factor 9 7 
Rora RAR-related orphan receptor alpha 7 
Arc activity regulated cytoskeletal-associated protein 7 
Ahr aryl-hydrocarbon receptor 7 
Smad7 SMAD family member 7 7 
Rragd Ras-related GTP binding D 7 
Spry4 sprouty homolog 4 (Drosophila) 7 
Sh3yl1 Sh3 domain YSC-like 1 7 
Ttc12 tetratricopeptide repeat domain 12 7 
Hist1h4m histone cluster 1, H4m 7 
Wdr65 NA 7 
Acot2 acyl-CoA thioesterase 2 7 
Hmcn1 hemicentin 1 7 
Hs3st1 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 7 
Il1rn interleukin 1 receptor antagonist 7 
Pcdh1 protocadherin 1 7 
Dusp10 dual specificity phosphatase 10 6 
Ppp1r15a protein phosphatase 1, regulatory (inhibitor) subunit 15A 6 
Coro6 coronin 6 6 
Sel1l3 sel-1 suppressor of lin-12-like 3 (C. elegans) 6 
Rnf183 ring finger protein 183 6 
Dysf dysferlin 6 
Smox spermine oxidase 6 
Il1a interleukin 1 alpha 6 
Zfp462 zinc finger protein 462 6 
Bcar3 breast cancer anti-estrogen resistance 3 6 
Cmpk2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial 6 
Serpinb9 serine (or cysteine) peptidase inhibitor, clade B, member 9 6 
Pou6f1 POU domain, class 6, transcription factor 1 6 
Adamts1 a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 1 
6 
Ifi204 interferon activated gene 204 6 
F3 coagulation factor III 6 
Hmox1 heme oxygenase 1 6 
Hilpda hypoxia inducible lipid droplet associated 6 
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Arnt2 aryl hydrocarbon receptor nuclear translocator 2 6 
Oasl2 2'-5' oligoadenylate synthetase-like 2 6 
Pla2g5 phospholipase A2, group V 6 
Ccdc92 coiled-coil domain containing 92 6 
Pim1 proviral integration site 1 6 
Slc39a2 solute carrier family 39 (zinc transporter), member 2 6 
Ankrd50 ankyrin repeat domain 50 6 
Epb4.1l1 NA 6 
Kdm7a lysine (K)-specific demethylase 7A 6 
Tinagl1 tubulointerstitial nephritis antigen-like 1 6 
Klf4 Kruppel-like factor 4 (gut) 6 
Smtn smoothelin 6 
Srgn serglycin 6 
Serpinb9b serine (or cysteine) peptidase inhibitor, clade B, member 9b 6 
Chac1 ChaC, cation transport regulator 1 6 
Nxph3 neurexophilin 3 6 
Aim1 absent in melanoma 1 6 
Xaf1 XIAP associated factor 1 6 
Ankrd33b ankyrin repeat domain 33B 6 
Mgarp mitochondria localized glutamic acid rich protein 6 
Spry2 sprouty homolog 2 (Drosophila) 6 
Slc22a4 solute carrier family 22 (organic cation transporter), member 4 6 
Trim30d tripartite motif-containing 30D 6 
Optn optineurin 6 
Zfr2 zinc finger RNA binding protein 2 6 
Gm6634 predicted gene 6634 6 
Prss50 protease, serine 50 6 
Tnfsf18 tumor necrosis factor (ligand) superfamily, member 18 6 
Phlda1 pleckstrin homology-like domain, family A, member 1 6 
Sqstm1 sequestosome 1 5 
Zdhhc18 zinc finger, DHHC domain containing 18 5 
Ndst3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 5 
Cx3cl1 chemokine (C-X3-C motif) ligand 1 5 
Gata3 GATA binding protein 3 5 
Treml4 triggering receptor expressed on myeloid cells-like 4 5 
Rasgef1a RasGEF domain family, member 1A 5 
Rab15 RAB15, member RAS oncogene family 5 
Thbs1 thrombospondin 1 5 
Mapre3 microtubule-associated protein, RP/EB family, member 3 5 
Dok7 docking protein 7 5 
Ptgir prostaglandin I receptor (IP) 5 
Ppfibp2 PTPRF interacting protein, binding protein 2 (liprin beta 2) 5 
Rnf19b ring finger protein 19B 5 
Fam13a family with sequence similarity 13, member A 5 
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H2-Q8 histocompatibility 2, Q region locus 8 5 
Gm7609 predicted pseudogene 7609 5 
Plk2 polo-like kinase 2 5 
Slc22a18 solute carrier family 22 (organic cation transporter), member 18 5 
Perm1 PPARGC1 and ESRR induced regulator, muscle 1 5 
Lims2 LIM and senescent cell antigen like domains 2 5 
Kdm6b KDM1 lysine (K)-specific demethylase 6B 5 
Mx2 MX dynamin-like GTPase 2 5 
Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 5 
Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 
9 
5 
Tgm1 transglutaminase 1, K polypeptide 5 
Sema3c sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3C 
5 
Kpna4 karyopherin (importin) alpha 4 5 
Tnfrsf9 tumor necrosis factor receptor superfamily, member 9 5 
Rasip1 Ras interacting protein 1 5 
Arid3b AT rich interactive domain 3B (BRIGHT-like) 5 
Padi2 peptidyl arginine deiminase, type II 5 
Plcl1 phospholipase C-like 1 5 
Plk3 polo-like kinase 3 5 
Hivep2 human immunodeficiency virus type I enhancer binding protein 2 5 
Sez6l2 seizure related 6 homolog like 2 5 
Sgk1 serum/glucocorticoid regulated kinase 1 5 
Ets1 E26 avian leukemia oncogene 1, 5' domain 5 
Plin2 perilipin 2 5 
Gpr141 G protein-coupled receptor 141 5 
Fzd5 frizzled homolog 5 (Drosophila) 5 




Supplementary table 4: Mn treatment caused downregulation in the genes in microglia 
>5 fold 
Gene Name Fold 
change 
Hp haptoglobin -79 
Cx3cr1 chemokine (C-X3-C motif) receptor 1 -14 
Asb10 ankyrin repeat and SOCS box-containing 10 -12 
Kmo kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) -12 
Ttn titin -12 
Gm5086 predicted gene 5086 -11 
D730005E14Rik RIKEN cDNA D730005E14 gene -10 
Abca9 ATP-binding cassette, sub-family A (ABC1), member 9 -8 
Sema4g sema domain, immunoglobulin domain (Ig), transmembrane 
domain (TM) and short cytoplasmic domain, (semaphorin) 4G 
-8 
4930558J18Rik RIKEN cDNA 4930558J18 gene -8 
Ankle1 ankyrin repeat and LEM domain containing 1 -8 
Tlr2 toll-like receptor 2 -7 
Pif1 PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) -7 
Hist1h2ao histone cluster 1, H2ao -7 
Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) -7 
Ttc30a1 tetratricopeptide repeat domain 30A1 -7 
Tmem51 transmembrane protein 51 -7 
Ppfia4 protein tyrosine phosphatase, receptor type, f polypeptide 
(PTPRF), interacting protein (liprin), alpha 4 
-6 
Gpr34 G protein-coupled receptor 34 -6 
Camk2a calcium/calmodulin-dependent protein kinase II alpha -6 
Cp ceruloplasmin -6 
Cd24a CD24a antigen -6 
Saa3 serum amyloid A 3 -6 
Csf3r colony stimulating factor 3 receptor (granulocyte) -6 
AA388235 expressed sequence AA388235 -6 
Acat2 acetyl-Coenzyme A acetyltransferase 2 -6 
Ms4a6c membrane-spanning 4-domains, subfamily A, member 6C -6 
Xkr5 X Kell blood group precursor-related family, member 5 -6 
Gpr183 G protein-coupled receptor 183 -6 
Lrfn1 leucine rich repeat and fibronectin type III domain containing 1 -6 
Aspm asp (abnormal spindle)-like, microcephaly associated (Drosophila) -6 
2810055G20Rik NA -6 
Armc2 armadillo repeat containing 2 -6 
Car9 carbonic anhydrase 9 -6 
Klhl23 kelch-like 23 -5 
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Ccbl2 cysteine conjugate-beta lyase 2 -5 
Sesn1 sestrin 1 -5 
Rassf4 Ras association (RalGDS/AF-6) domain family member 4 -5 
Arhgap19 Rho GTPase activating protein 19 -5 
Tha1 threonine aldolase 1 -5 
Nrp NA -5 




Supplementary table 5: Mn and misfolded α-Synuclein co-treatment caused 
upregulation in the genes in microglia >5 fold 
Gene Name Fold 
change 
Il6 interleukin 6 3407 
Urah urate (5-hydroxyiso-) hydrolase 1453 
Nos2 nitric oxide synthase 2, inducible 1141 
Lcn2 lipocalin 2 1134 
Csf3 colony stimulating factor 3 (granulocyte) 1099 
Il12b interleukin 12b 788 
Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 672 
Il1b interleukin 1 beta 664 
Mmp3 matrix metallopeptidase 3 629 
Il1f6 interleukin 1 family, member 6 513 
Slfn1 schlafen 1 465 
Ptgs2os prostaglandin-endoperoxide synthase 2, opposite strand 319 
Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, member 2 293 
Cxcl3 chemokine (C-X-C motif) ligand 3 278 
Il1a interleukin 1 alpha 269 
Bcl2a1a B cell leukemia/lymphoma 2 related protein A1a 242 
H2-Q9 histocompatibility 2, Q region locus 9 231 
Ptgs2 prostaglandin-endoperoxide synthase 2 222 
Sstr5 somatostatin receptor 5 202 
Ccl5 chemokine (C-C motif) ligand 5 181 
Cxcl2 chemokine (C-X-C motif) ligand 2 174 
Mmp13 matrix metallopeptidase 13 156 
Gm5483 predicted gene 5483 138 
Ifnb1 interferon beta 1, fibroblast 132 
Cemip cell migration inducing protein, hyaluronan binding 128 
Plagl1 pleiomorphic adenoma gene-like 1 125 
Traf1 TNF receptor-associated factor 1 123 
Tmc7 transmembrane channel-like gene family 7 121 
Dio2 deiodinase, iodothyronine, type II 121 
Pydc4 pyrin domain containing 4 119 
AA467197 expressed sequence AA467197 115 
Mmp10 matrix metallopeptidase 10 110 
Rsad2 radical S-adenosyl methionine domain containing 2 110 
Ggt1 gamma-glutamyltransferase 1 108 
Gm5416 predicted gene 5416 102 
Upp1 uridine phosphorylase 1 100 
BC100530 cDNA sequence BC100530 100 
Pgf placental growth factor 96 
Lif leukemia inhibitory factor 94 
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Supplementary table 5 (continued) 
Rgs9 regulator of G-protein signaling 9 94 
Tpbg trophoblast glycoprotein 90 
Gpr126 NA 79 
Procr protein C receptor, endothelial 75 
Zbp1 Z-DNA binding protein 1 74 
Tnn tenascin N 67 
Rtn4r reticulon 4 receptor 65 
Isg15 ISG15 ubiquitin-like modifier 64 
Car6 carbonic anhydrase 6 62 
Spta1 spectrin alpha, erythrocytic 1 59 
Osbp2 oxysterol binding protein 2 56 
Agpat9 1-acylglycerol-3-phosphate O-acyltransferase 9 55 




Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 49 
Ccl12 chemokine (C-C motif) ligand 12 48 
2010005H1
5Rik 
RIKEN cDNA 2010005H15 gene 47 
Cmpk2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial 47 
Cxcl10 chemokine (C-X-C motif) ligand 10 45 
Zfp811 zinc finger protein 811 45 
Wnt9a wingless-type MMTV integration site family, member 9A 45 
Fam19a2 family with sequence similarity 19, member A2 45 
Ifit1 interferon-induced protein with tetratricopeptide repeats 1 44 
Irg1 immunoresponsive gene 1 43 
Stmn4 stathmin-like 4 43 
Isg20 interferon-stimulated protein 43 
Dusp1 dual specificity phosphatase 1 42 
Pydc3 pyrin domain containing 3 42 
Edn1 endothelin 1 41 
Gm6460 predicted gene 6460 38 
Dusp5 dual specificity phosphatase 5 36 
Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 34 
Gm13889 predicted gene 13889 33 
Gbp5 guanylate binding protein 5 32 
Pyhin1 pyrin and HIN domain family, member 1 32 
Ccbe1 collagen and calcium binding EGF domains 1 30 
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 30 
Fam171b family with sequence similarity 171, member B 30 
Myc myelocytomatosis oncogene 30 
Tarm1 T cell-interacting, activating receptor on myeloid cells 1 30 
Hdc histidine decarboxylase 30 
Dusp8 dual specificity phosphatase 8 29 
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Supplementary table 5 (continued) 
Il27 interleukin 27 29 
Ccr3 chemokine (C-C motif) receptor 3 29 
Slc6a19 solute carrier family 6 (neurotransmitter transporter), member 19 28 
Apol9b apolipoprotein L 9b 27 
Sh2d2a SH2 domain containing 2A 27 
Lrrc32 leucine rich repeat containing 32 26 
Gbp2 guanylate binding protein 2 26 
Col4a2 collagen, type IV, alpha 2 25 
Mylk2 myosin, light polypeptide kinase 2, skeletal muscle 25 
Gbp4 guanylate binding protein 4 25 
Cdkn1c cyclin-dependent kinase inhibitor 1C (P57) 25 
Cd274 CD274 antigen 25 
Aqp9 aquaporin 9 25 
Gprc5a G protein-coupled receptor, family C, group 5, member A 25 
Gpr124 NA 25 
Ddit3 DNA-damage inducible transcript 3 25 
Rhov ras homolog gene family, member V 25 
Prph peripherin 23 
Ahr aryl-hydrocarbon receptor 23 
Il1f9 interleukin 1 family, member 9 23 
Mx2 MX dynamin-like GTPase 2 23 
Pxdc1 PX domain containing 1 21 
Prkg2 protein kinase, cGMP-dependent, type II 21 
Ifit2 interferon-induced protein with tetratricopeptide repeats 2 21 
Sdcbp2 syndecan binding protein (syntenin) 2 21 
Tgm1 transglutaminase 1, K polypeptide 21 
Avil advillin 20 
Hoxa5 homeobox A5 20 
Vegfc vascular endothelial growth factor C 20 
Apol9a apolipoprotein L 9a 20 
Fam71f2 family with sequence similarity 71, member F2 19 
Ccrl2 chemokine (C-C motif) receptor-like 2 19 
Col5a1 collagen, type V, alpha 1 18 
B230312C0
2Rik 
RIKEN cDNA B230312C02 gene 18 
Thbs1 thrombospondin 1 18 
Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 18 
Csrnp1 cysteine-serine-rich nuclear protein 1 17 
6530402F1
8Rik 
RIKEN cDNA 6530402F18 gene 17 
Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B cells 
inhibitor, zeta 
17 
Cdcp1 CUB domain containing protein 1 17 
Ntng2 netrin G2 17 
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Supplementary table 5 (continued) 
Efcab6 EF-hand calcium binding domain 6 17 
P4ha2 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), alpha II polypeptide 
16 
Arid3b AT rich interactive domain 3B (BRIGHT-like) 16 
Lta lymphotoxin A 16 
Tnfsf15 tumor necrosis factor (ligand) superfamily, member 15 16 
Socs1 suppressor of cytokine signaling 1 16 
Il1rn interleukin 1 receptor antagonist 16 
A530032D1
5Rik 
RIKEN cDNA A530032D15Rik gene 16 
Adm adrenomedullin 16 
Nyap2 neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 16 
Gipr gastric inhibitory polypeptide receptor 15 
A530064D0
6Rik 
RIKEN cDNA A530064D06 gene 15 
AW011738 expressed sequence AW011738 15 
Plat plasminogen activator, tissue 15 
Dusp10 dual specificity phosphatase 10 15 
Pim1 proviral integration site 1 14 
Src Rous sarcoma oncogene 14 
Mmp12 matrix metallopeptidase 12 14 
Rhou ras homolog gene family, member U 14 
Cish cytokine inducible SH2-containing protein 14 
Gadd45a growth arrest and DNA-damage-inducible 45 alpha 14 
Gbp3 guanylate binding protein 3 14 
Gdf15 growth differentiation factor 15 13 
Arg1 arginase, liver 13 
Gbp7 guanylate binding protein 7 13 
Lix1 limb expression 1 homolog (chicken) 13 
Sema3e sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3E 
13 
Ptger2 prostaglandin E receptor 2 (subtype EP2) 13 
Dok7 docking protein 7 13 
Ifi204 interferon activated gene 204 13 
Tnfrsf9 tumor necrosis factor receptor superfamily, member 9 13 
A1cf APOBEC1 complementation factor 13 
Ccl7 chemokine (C-C motif) ligand 7 13 
Mnda myeloid cell nuclear differentiation antigen 13 
Trim30d tripartite motif-containing 30D 13 
Gm14446 NA 13 
Pilrb1 paired immunoglobin-like type 2 receptor beta 1 13 
Bcar1 breast cancer anti-estrogen resistance 1 13 
Hist1h4m histone cluster 1, H4m 13 
Srgn serglycin 13 
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Supplementary table 5 (continued) 
Ifi202b interferon activated gene 202B 13 
Mgam maltase-glucoamylase 13 
Oasl1 2'-5' oligoadenylate synthetase-like 1 12 
Ifi205 interferon activated gene 205 12 
Ier3 immediate early response 3 12 
Trib3 tribbles homolog 3 (Drosophila) 12 
4933432I03
Rik 
RIKEN cDNA 4933432I03 gene 12 
Ifi44 interferon-induced protein 44 12 
Dusp14 dual specificity phosphatase 14 12 
Cd83 CD83 antigen 12 
Slc15a3 solute carrier family 15, member 3 12 
Ppfibp2 PTPRF interacting protein, binding protein 2 (liprin beta 2) 12 
Nupr1 nuclear protein transcription regulator 1 11 
Syt7 synaptotagmin VII 11 
Oasl2 2'-5' oligoadenylate synthetase-like 2 11 
Phlda1 pleckstrin homology-like domain, family A, member 1 11 
Irf7 interferon regulatory factor 7 11 
Xaf1 XIAP associated factor 1 11 
Usp18 ubiquitin specific peptidase 18 11 
Pfn2 profilin 2 11 
Slamf7 SLAM family member 7 11 
Slc35f1 solute carrier family 35, member F1 10 
Jag1 jagged 1 10 
Slc16a14 solute carrier family 16 (monocarboxylic acid transporters), member 14 10 
Smad7 SMAD family member 7 10 
Socs2 suppressor of cytokine signaling 2 10 
Hid1 HID1 domain containing 10 
F3 coagulation factor III 10 
Ccl3 chemokine (C-C motif) ligand 3 10 
Hilpda hypoxia inducible lipid droplet associated 10 
Fignl2 fidgetin-like 2 10 
Furin furin (paired basic amino acid cleaving enzyme) 10 
Sdk2 sidekick homolog 2 (chicken) 10 
Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b 10 
Ccl22 chemokine (C-C motif) ligand 22 9 
Perm1 PPARGC1 and ESRR induced regulator, muscle 1 9 
Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 9 
Tnfaip3 tumor necrosis factor, alpha-induced protein 3 9 
Mxd1 MAX dimerization protein 1 9 
Slc24a1 solute carrier family 24 (sodium/potassium/calcium exchanger), 
member 1 
9 
Hist2h2aa1 histone cluster 2, H2aa1 9 
Cd69 CD69 antigen 9 
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Arc activity regulated cytoskeletal-associated protein 9 
Rnd3 Rho family GTPase 3 9 
Pla1a phospholipase A1 member A 9 
Lat linker for activation of T cells 9 
Acsbg1 acyl-CoA synthetase bubblegum family member 1 9 
Pilra paired immunoglobin-like type 2 receptor alpha 9 
Ddit4 DNA-damage-inducible transcript 4 9 
Plk2 polo-like kinase 2 9 
Ccl2 chemokine (C-C motif) ligand 2 9 
Ppp1r15a protein phosphatase 1, regulatory (inhibitor) subunit 15A 9 
Nox3 NADPH oxidase 3 9 
Tmem132a transmembrane protein 132A 8 
Cyr61 cysteine rich protein 61 8 
Scg2 secretogranin II 8 
Mfap3l microfibrillar-associated protein 3-like 8 
Plcl1 phospholipase C-like 1 8 
Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) 8 
Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 11 
8 
Ndrg1 N-myc downstream regulated gene 1 8 
Rapgef5 Rap guanine nucleotide exchange factor (GEF) 5 8 
Itga3 integrin alpha 3 8 
Cd40 CD40 antigen 8 
Rnf19b ring finger protein 19B 8 
Atf3 activating transcription factor 3 8 
Ankrd33b ankyrin repeat domain 33B 8 
Smox spermine oxidase 8 
Lamc2 laminin, gamma 2 8 
Sqstm1 sequestosome 1 8 
Slc22a4 solute carrier family 22 (organic cation transporter), member 4 8 
Atp13a4 ATPase type 13A4 8 
Hmox1 heme oxygenase 1 8 
Gbp6 guanylate binding protein 6 8 
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 8 
Sccpdh saccharopine dehydrogenase (putative) 8 
Tiparp TCDD-inducible poly(ADP-ribose) polymerase 8 
Mx1 MX dynamin-like GTPase 1 8 
Ccdc136 coiled-coil domain containing 136 8 
Sema3c sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3C 
8 
Stk40 serine/threonine kinase 40 8 
Rtp4 receptor transporter protein 4 7 
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Supplementary table 5 (continued) 
Ifih1 interferon induced with helicase C domain 1 7 
Chac1 ChaC, cation transport regulator 1 7 
Dusp13 dual specificity phosphatase 13 7 
Gm20594 predicted gene, 20594 7 
Moap1 modulator of apoptosis 1 7 
9430076C1
5Rik 
RIKEN cDNA 9430076C15 gene 7 
Rgag4 retrotransposon gag domain containing 4 7 
Tnf tumor necrosis factor 7 
Alas1 aminolevulinic acid synthase 1 7 
Sh3yl1 Sh3 domain YSC-like 1 7 
Mreg melanoregulin 7 
Slc6a12 solute carrier family 6 (neurotransmitter transporter, betaine/GABA), 
member 12 
7 
Gm7609 predicted pseudogene 7609 7 
Dnajb9 DnaJ (Hsp40) homolog, subfamily B, member 9 7 
Trpm4 transient receptor potential cation channel, subfamily M, member 4 7 
Evi2a-evi2b NA 7 
Fcrlb Fc receptor-like B 7 
Pla2g5 phospholipase A2, group V 7 
Abcb9 ATP-binding cassette, sub-family B (MDR/TAP), member 9 7 
Hist1h4h histone cluster 1, H4h 7 
Nox1 NADPH oxidase 1 7 
Rdh12 retinol dehydrogenase 12 7 
Slc39a2 solute carrier family 39 (zinc transporter), member 2 7 
Osm oncostatin M 6 
Prickle1 prickle homolog 1 (Drosophila) 6 
Zc3h12a zinc finger CCCH type containing 12A 6 
B430306N0
3Rik 
RIKEN cDNA B430306N03 gene 6 
Mtmr7 myotubularin related protein 7 6 
Scimp SLP adaptor and CSK interacting membrane protein 6 
Helz2 helicase with zinc finger 2, transcriptional coactivator 6 
Tnnc1 troponin C, cardiac/slow skeletal 6 
Mt2 metallothionein 2 6 
Herc6 hect domain and RLD 6 6 
Trem1 triggering receptor expressed on myeloid cells 1 6 
Epha2 Eph receptor A2 6 
Acoxl acyl-Coenzyme A oxidase-like 6 
Fam46c family with sequence similarity 46, member C 6 
Plxna4os1 plexin A4, opposite strand 1 6 
Lamb3 laminin, beta 3 6 
Ptgir prostaglandin I receptor (IP) 6 
Ero1l ERO1-like (S. cerevisiae) 6 
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Supplementary table 5 (continued) 
Csn3 casein kappa 6 
Parp14 poly (ADP-ribose) polymerase family, member 14 6 
Col11a2 collagen, type XI, alpha 2 6 
Id2 inhibitor of DNA binding 2 6 
Jazf1 JAZF zinc finger 1 6 
Rgs1 regulator of G-protein signaling 1 6 
Lhx2 LIM homeobox protein 2 6 
Sp140 Sp140 nuclear body protein 6 
Stat2 signal transducer and activator of transcription 2 6 
Pilrb2 paired immunoglobin-like type 2 receptor beta 2 6 
Tmc3 transmembrane channel-like gene family 3 6 
Ccdc92 coiled-coil domain containing 92 6 
Kctd12 potassium channel tetramerisation domain containing 12 6 
Wfdc17 WAP four-disulfide core domain 17 6 
Adcy3 adenylate cyclase 3 6 
Marcks myristoylated alanine rich protein kinase C substrate 6 
Btg1 B cell translocation gene 1, anti-proliferative 6 
Ntn1 netrin 1 6 
Il4ra interleukin 4 receptor, alpha 6 
Plag1 pleiomorphic adenoma gene 1 6 
Oas1b 2'-5' oligoadenylate synthetase 1B 6 
Gbp9 guanylate-binding protein 9 6 
Fndc9 fibronectin type III domain containing 9 6 
Gpr31b G protein-coupled receptor 31, D17Leh66b region 6 
Ddx60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 6 
Pacrg PARK2 co-regulated 6 
Sez6l2 seizure related 6 homolog like 2 6 
Rabgef1 RAB guanine nucleotide exchange factor (GEF) 1 6 
Gucy2g guanylate cyclase 2g 6 
Hcar2 hydroxycarboxylic acid receptor 2 6 
Kpna4 karyopherin (importin) alpha 4 6 
Grb10 growth factor receptor bound protein 10 6 
Gdnf glial cell line derived neurotrophic factor 6 
Ankrd50 ankyrin repeat domain 50 6 
Gfod1 glucose-fructose oxidoreductase domain containing 1 6 
Rasip1 Ras interacting protein 1 6 
Rbpms2 RNA binding protein with multiple splicing 2 6 
Kcnab1 potassium voltage-gated channel, shaker-related subfamily, beta 
member 1 
6 
Pdgfa platelet derived growth factor, alpha 6 
Psd2 pleckstrin and Sec7 domain containing 2 6 
Ttc39c tetratricopeptide repeat domain 39C 6 
Phf11d PHD finger protein 11D 5 
Socs3 suppressor of cytokine signaling 3 5 
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Supplementary table 5 (continued) 
Casp4 caspase 4, apoptosis-related cysteine peptidase 5 
Rora RAR-related orphan receptor alpha 5 
Stx11 syntaxin 11 5 
Ccl4 chemokine (C-C motif) ligand 4 5 
Gnb4 guanine nucleotide binding protein (G protein), beta 4 5 
Dcbld2 discoidin, CUB and LCCL domain containing 2 5 
Hivep2 human immunodeficiency virus type I enhancer binding protein 2 5 
Trim30a tripartite motif-containing 30A 5 
Dhx58 DEXH (Asp-Glu-X-His) box polypeptide 58 5 
Tmem171 transmembrane protein 171 5 
Gm6634 predicted gene 6634 5 
Zfp703 zinc finger protein 703 5 
Cd72 CD72 antigen 5 
Atp7b ATPase, Cu++ transporting, beta polypeptide 5 
Bcl2a1d B cell leukemia/lymphoma 2 related protein A1d 5 
Tmem236 transmembrane protein 236 5 
Cdc42ep2 CDC42 effector protein (Rho GTPase binding) 2 5 
Tnfrsf23 tumor necrosis factor receptor superfamily, member 23 5 
Rnf183 ring finger protein 183 5 
C130026I21
Rik 
RIKEN cDNA C130026I21 gene 5 
Rgs12 regulator of G-protein signaling 12 5 
Zdhhc18 zinc finger, DHHC domain containing 18 5 
Ccr1 chemokine (C-C motif) receptor 1 5 
Fam214b family with sequence similarity 214, member B 5 
Slfn4 schlafen 4 5 
Rgs16 regulator of G-protein signaling 16 5 
Cd22 CD22 antigen 5 
Irgm1 immunity-related GTPase family M member 1 5 
St3gal1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 5 
Ticam1 toll-like receptor adaptor molecule 1 5 
Gadd45b growth arrest and DNA-damage-inducible 45 beta 5 
Glipr2 GLI pathogenesis-related 2 5 
Arhgef3 Rho guanine nucleotide exchange factor (GEF) 3 5 
Smim3 small integral membrane protein 3 5 
11-Mar membrane-associated ring finger (C3HC4) 11 5 
Gimap6 GTPase, IMAP family member 6 5 
Cpd carboxypeptidase D 5 
Nckap1 NCK-associated protein 1 5 
Lims2 LIM and senescent cell antigen like domains 2 5 
Serpinb9 serine (or cysteine) peptidase inhibitor, clade B, member 9 5 
Casz1 castor zinc finger 1 5 
Zfp36 zinc finger protein 36 5 
Galnt3 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-ag3 5 
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Supplementary table 6: Mn and misfolded α-Synuclein co-treatment caused 
downregulation in the genes in microglia >5 fold 
Gene Name Fold 
change 
Cecr6 cat eye syndrome chromosome region, candidate 6 -179 
Sema4g sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cytoplasmic domain, (semaphorin) 4G 
-54 
Tspan10 tetraspanin 10 -46 
Serpinb1
a 
serine (or cysteine) peptidase inhibitor, clade B, member 1a -25 
Ocstamp osteoclast stimulatory transmembrane protein -22 
Cx3cr1 chemokine (C-X3-C motif) receptor 1 -17 
Lifr leukemia inhibitory factor receptor -16 
Asb10 ankyrin repeat and SOCS box-containing 10 -16 
Cd24a CD24a antigen -14 
Camk2b calcium/calmodulin-dependent protein kinase II, beta -14 
Gm5086 predicted gene 5086 -12 
Slc14a1 solute carrier family 14 (urea transporter), member 1 -12 
Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) -12 
Klhl38 kelch-like 38 -12 
Fcrls Fc receptor-like S, scavenger receptor -10 
Klrd1 killer cell lectin-like receptor, subfamily D, member 1 -9 
Srpk3 serine/arginine-rich protein specific kinase 3 -9 
Pdk2 pyruvate dehydrogenase kinase, isoenzyme 2 -9 
Armc2 armadillo repeat containing 2 -9 
Pacsin1 protein kinase C and casein kinase substrate in neurons 1 -8 
Mn1 meningioma 1 -8 
Gpr162 G protein-coupled receptor 162 -7 
Cmbl carboxymethylenebutenolidase-like (Pseudomonas) -7 
Pianp PILR alpha associated neural protein -6 
Lsp1 lymphocyte specific 1 -6 
Crip1 cysteine-rich protein 1 (intestinal) -6 
Ppfia4 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), 
interacting protein (liprin), alpha 4 
-6 
Lrrc14b leucine rich repeat containing 14B -6 
Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 -5 
Kcne3 potassium voltage-gated channel, Isk-related subfamily, gene 3 -5 
9330188
P03Rik 
RIKEN cDNA 9330188P03 gene -5 
Aif1 allograft inflammatory factor 1 -5 
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M1 classic phenotype (cytotoxic) 
   
  
IL-1b 345 4 664   
IL-6 714 52 3407   
IL-12b 4 6 788   
IFNb1 7 52 132   
CXCL2 37 13 174   
CXCL3 125 17 278   
CXCL10 20 3 45   
IL-1a 190 6 269   
IL-2 
   
  
CCL5 (RANTES) 43 4 181   
Cox-2 
   
M2a alternate phenotype (repair and regeneration) 




IL-4ra 3 2 6 
  




-17 -14 -31 
  
Tab1 -1 -1 -1   
TGF-b1 1 1 1   
Tgfbr1 -2 -2 -2   
Tgfbr2 -2 -1 -1   
Tgfbrap1 -1 -1 -1   
CD40 3 3 8   
CD74  2 -2 2   




   
  
Hexa -1 1 -1   
FIZZ1 -1 -1 -1   
IGF-1r -1 -2 -2   
IGF-1 -4 -2 -4   
Igf2bp2 3 2 4   
Igfbp4 -2 -2 -5   
Arg1 3 12 13       
M2b (c) Type II-deactivating phenotype (immunomodulatory) 
   
      
  
IL-10 -1 1 -1       
  
Cox-2 
   
  
SphK2 1 2 3 
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Gene Name Syn Mn Mn+ 
Syn 
Ccrl2 chemokine (C-C motif) receptor-like 2 2.9 1.1 19.1 
Cd83 CD83 antigen -2.6 3.2 11.7 
Cd14 CD14 antigen 2.8 2.0 4.8 
Itgam integrin alpha M 2.0 1.7 2.5 
H2-K1 histocompatibility 2, K1, K region 1.0 1.4 2.1 
B2m beta-2 microglobulin 1.3 1.6 1.8 
Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a -1.2 1.3 1.5 
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide 1.1 1.2 1.2 
Icam1 intercellular adhesion molecule 1 1.1 -1.5 1.2 
Fcgr3 Fc receptor, IgG, low affinity III -1.0 1.2 -1.0 
Csf1r colony stimulating factor 1 receptor -1.2 -1.6 -1.3 
Sirpa signal-regulatory protein alpha -1.4 -1.4 -1.5 
Tyrobp TYRO protein tyrosine kinase binding protein -1.7 -1.5 -1.7 
P2ry13 purinergic receptor P2Y, G-protein coupled 13 -1.3 -5.0 -3.2 
Trem2 triggering receptor expressed on myeloid cells 2 -2.2 -1.8 -3.8 
P2ry12 purinergic receptor P2Y, G-protein coupled 12 -1.2 -2.0 -4.9 
Gpr183 G protein-coupled receptor 183 -3.2 -5.9 -17.3 
Cx3cr1 chemokine (C-X3-C motif) receptor 1 -17.5 -14.1 -31.0 
Ccrl2 chemokine (C-C motif) receptor-like 2 2.9 1.1 19.1 
Cd83 CD83 antigen -2.6 3.2 11.7 
Cd14 CD14 antigen 2.8 2.0 4.8 
Itgam integrin alpha M 2.0 1.7 2.5 
H2-K1 histocompatibility 2, K1, K region 1.0 1.4 2.1 
B2m beta-2 microglobulin 1.3 1.6 1.8 
Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a -1.2 1.3 1.5 
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide 1.1 1.2 1.2 
Icam1 intercellular adhesion molecule 1 1.1 -1.5 1.2 
Fcgr3 Fc receptor, IgG, low affinity III -1.0 1.2 -1.0 
Csf1r colony stimulating factor 1 receptor -1.2 -1.6 -1.3 
Sirpa signal-regulatory protein alpha -1.4 -1.4 -1.5 
Tyrobp TYRO protein tyrosine kinase binding protein -1.7 -1.5 -1.7 
P2ry13 purinergic receptor P2Y, G-protein coupled 13 -1.3 -5.0 -3.2 
Trem2 triggering receptor expressed on myeloid cells 2 -2.2 -1.8 -3.8 
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Figure 1: Transcriptomic profiling of microglial responses to misfolded α-Synuclein 
(A) differentially expressed microglia transcripts in response to α-syn. Volcano plots of 
genes that are that are significantly different, upregulated (shown in red) or downregulated 
(green dots). (B) Hierarchical clustering of top 50 upregulated genes and top 50 down-
regulated genes induced αSyn. (C) Reactome enrichment plots illustrating top pathways and 




















Figure 2: Transcriptomic profiling of microglial responses to Manganese 
(A) differentially expressed microglia transcripts in response to Mn. Volcano plots of genes 
that are that are significantly different, upregulated (shown in red) or downregulated (green 
dots). (B) Heat maps of top 50 upregulated genes and top 50 down-regulated genes induced 
Mn. (C) Reactome enrichment plots illustrating top pathways and biological processes that 
are altered in response to Mn treatment.  
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Figure 2 (Continued) 
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Figure 3: Transcriptomic profiling of microglial responses to Manganese and α-
Synuclein co-treatment 
(A) differentially expressed microglia transcripts in response to Mn and α-Syn co-treatment. 
Volcano plots of genes that are that are significantly different, upregulated (shown in red) or 
downregulated (green dots). (B) Heat maps of top 50 upregulated genes and top 50 down-
regulated genes induced Mn and α-Syn co-treatment. (C) Reactome enrichment plots 




Fig. 3 (Continued) 
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Figure 4: RNA-seq demonstrate distinct response in gene expression 
(A) Schematic view of data from RNA-Seq using Venn diagram showing the overlaps between 
the differentially expressed genes (DEGs) in microglial responses to α-Syn, Mn, and their co-
treatments. The overlap between the two circles indicates the number of genes differentially 
expressed by both treatments. (B) Heatmap representation of RNA-seq data showing 





Figure 5: RNA-seq demonstrate distinct response in gene expression 
RT-qPCR quantification of the genes expression levels in microglia in response to α-Synuclein 
and prion proteins. Increase in pro-inflammatory genes IL-6, NOS-2, IL-1β, TNF-α, IL-12 and 






Figure 6: Verification of protein expression using dot blots increased or decreased genes 
Dot blots to verify the protein expression changes as quantification of the genes expression 
levels in microglia in response to α-Syn, Mn and their co-treatments. Increase in pro-
inflammatory genes (A) Proteins with increased response to treatments are shown on left, 
TNFRII, NOS-2, pY311 PKCδ, PKCδ and P-AMPKα (T172) were increased. (B) Proteins 
with the decreased trend to treatments are shown on right, p67-phox H300, U1snRNP7, Bax, 
G3BP1 were decreased. 
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CHAPTER VI: GENERAL CONCLUSION AND FUTURE DIRECTIONS 
In this section, I present a general overview of the results from each chapter and how 
this fits in a global picture of each chapter in relation to their importance. We developed an 
organotypic brain slice culture model to understand the mechanism of misfolded protein 
pathology in the pathogenesis of protein misfolding disorders and overall implications of these 
findings in developing therapeutics (See Fig.1 below for other applications). We also used 
these models to understand mechanisms of neurotoxicity and characterized specific responses 
of Microglia in response to Manganese and α synuclein prions. The specific findings are 
covered under ‘results’ section and their implications can be found in ‘discussion’ section of 
the pertaining chapter. 
 In Chapter 1, we introduce an organotypic brain slice cultures as an ex-vivo model to 
study environmentally linked neurodegenerative diseases with a protein misfolding component 
as an etiological factor. We also reviewed, current knowledge on the applications of 
organotypic brain slices in diseases such as Alzheimer’s, Parkinson’s, Prion, Huntington’s, 
ALS, and TBI. The brain slices recapitulate key features of several disease phenotype and 
neurotoxicity as compared to the cell cultures. Some of the key advantages of using the slice 
cultures are that they are feasible to study protein aggregation as they allow chronic/long-term 
studies involving several weeks in a controlled environment. Although there are several 
advantages of using the slice culture model for neurotoxicity studies, the notable caveat of this 
model includes the time-intensive protocol to generate slices and particularly labor-intensive 
nature of the long-term maintenance of the cultures. To overcome these challenges, new tools 
that allow slice preparation in a more time efficient manner are needed. Further technological 
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advancements in the slice preparation and maintenance may help to address some of these 
concerns. 
In chapter II we provide a sensitive detection platform from prion-infected organotypic 
slice cultures termed as OSCAR assay (organotypic slice cultures coupled to RT-QuIC assay). 
Using this assay, lead compounds can be rapidly screened with very low protein requirement. 
This allows us to develop high-throughput models that are scalable. Further studies are 
underway to identify compounds that may uncouple seeding activity and or neurotoxicity in 
the slices. Neurodegenerative disorders such as Alzheimer’s and Parkinson’s have unique 
proteins that can be misfolded. Based on the existing evidence, we predict the OSCAR model 
can be translated to other protein misfolding disorders that obey protein-based aggregation 
phenomena. Another advantage of this model is that it requires less number of animals and is 
cost-effective. Further, we are using this model to understand mechanisms of protein 
aggregation. 
The findings reported in Chapter III demonstrate that organotypic slice cultures can be 
effectively used to model chronic wasting disease (CWD). CWD prions are difficult to 
replicate in the mouse as the prion protein gene sequence doesn’t effectively allow to cross 
seed the elk or deer prions. Therefore, we used a transgenic mouse that expresses elk prion 
protein sequence. Using Tg12 slice cultures we were able to develop a brain slice culture for 
CWD prions and thus reducing the time to study this chronic progressive disease that may take 
up to 3-5 years to study in cervids. 
In Chapter IV, we investigated the role of microglia in Manganese and α-Syn induced 
inflammation at transcriptomic level. Mn is richly distributed in welding fumes and is also 
known to cross the blood-brain barrier as well as it could pass through the intranasal route to 
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lungs. Thus, Mn can enter the brain directly in high-risk groups such as welders and miners 
and cause a Parkinsonian syndrome. The interaction of Mn with α-Syn is investigated as it 
could trigger a deteriorating inflammation and thus may lead to neurological disease. 
Furthermore, we identified key genes and pathways related to microglial dysfunction caused 
by Mn, α-Syn and their interaction. Further biochemical and molecular studies would allow us 
to identify specific targets that are druggable. This not only enhances our understanding of the 
fundamental mechanisms of drug targets but also an optimization of rational drug targets. 
Previous studies suggested Fyn and PKCδ play a central role in the Parkinson’s disease models.  
Misfolded aggregated α-synuclein can rapidly activate microglia and the effect of Mn on 
altering the phenotype is unknown. Using the transgenic knockout models of Fyn and PKCδ, 
we hope to understand the ability the key mechanisms involved in the microglia-mediated 
pathology. Further studies are being performed to validate promising targets in-vitro and in-




Figure 1: Schematic depiction of brain slice culture preparation and their applications 
Brains were dissected out from neonatal mice and region of interest (for example, 
cerebellum) will be oriented to the cutting plane (sections derived from sagittal plane is 
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shown). Slices will be processed as desired such as treatments with materials such as 
homogenates and washed. The slices will be transferred to a culture insert with nutrient media 
supplied at the basal chamber to permit an air-media interface for the slice cultures. These 
slices are accessible for a variety of applications such as protein misfolding modeling, 
functional and biochemical assays, and other translational approaches.  
